RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
|
G |
Mag |
myelin-associated glycoprotein |
|
IEP |
protein:decreased expression:optic nerve |
RGD |
PMID:9820787 |
RGD:9685300 |
NCBI chr 1:89,345,325...89,360,905
Ensembl chr 1:89,345,429...89,360,733
|
|
G |
Zc3h12a |
zinc finger CCCH type containing 12A |
disease_progression |
ISO |
|
RGD |
PMID:26320658 |
RGD:11534569 |
NCBI chr 5:143,111,342...143,120,131
Ensembl chr 5:143,111,074...143,120,165
|
|
|
G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16472600 PMID:29808285 |
|
NCBI chr 4:22,133,984...22,192,687
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23415960 |
|
NCBI chr 1:101,954,786...102,013,252
Ensembl chr 1:101,959,540...102,013,243
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:113,596,247...113,660,024
Ensembl chr X:113,596,239...113,659,944
|
|
G |
Ahcy |
adenosylhomocysteinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:150,587,833...150,603,057
Ensembl chr 3:150,587,833...150,603,082
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27869817 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr20:5,161,350...5,167,176
Ensembl chr20:5,161,333...5,166,448
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25658812 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16642209 PMID:17963606 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:259,641,673...259,674,521
Ensembl chr 1:259,641,676...259,674,425 Ensembl chr 1:259,641,676...259,674,425
|
|
G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29031482 |
|
NCBI chr17:42,133,076...42,159,413
Ensembl chr17:42,133,076...42,159,413
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27466191 |
|
NCBI chr 5:156,086,496...156,141,513
Ensembl chr 5:156,086,497...156,141,537
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:67,295,578...67,333,075
Ensembl chr 8:67,295,727...67,333,247
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12746438 PMID:16651627 PMID:25881725 PMID:27567873 PMID:31939705 |
|
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr18:6,766,009...6,782,757
Ensembl chr18:6,765,945...6,782,996
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863
|
|
G |
Artn |
artemin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27869817 |
|
NCBI chr 5:136,759,717...136,765,036
Ensembl chr 5:136,759,717...136,762,986
|
|
G |
Atp7a |
ATPase copper transporting alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17483305 |
|
NCBI chr X:77,076,085...77,193,644
Ensembl chr X:77,076,106...77,193,644
|
|
G |
Atp7b |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11803042 PMID:15911138 PMID:21146535 PMID:21364284 |
|
NCBI chr16:74,865,516...74,944,935
Ensembl chr16:74,865,516...74,945,286
|
|
G |
Axin2 |
axin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr10:97,212,483...97,238,824
Ensembl chr10:97,212,432...97,239,642
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30685357 |
|
NCBI chr 6:129,399,468...129,429,676
Ensembl chr 6:129,399,468...129,429,676
|
|
G |
Bscl2 |
BSCL2 lipid droplet biogenesis associated, seipin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25462787 |
|
NCBI chr 1:225,035,956...225,046,137
Ensembl chr 1:225,037,737...225,046,040
|
|
G |
Bzw2 |
basic leucine zipper and W2 domains 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 6:55,586,754...55,647,650
Ensembl chr 6:55,586,346...55,647,665
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26831068 |
|
NCBI chr16:6,110,294...6,405,022
Ensembl chr16:6,112,150...6,405,117
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr 1:184,184,018...184,188,922
Ensembl chr 1:184,184,020...184,188,911
|
|
G |
Caly |
calcyon neuron-specific vesicular protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30753204 |
|
NCBI chr 1:212,537,851...212,549,040
Ensembl chr 1:212,537,848...212,549,477
|
|
G |
Car2 |
carbonic anhydrase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15816485 |
|
NCBI chr 2:88,097,740...88,112,868
Ensembl chr 2:88,097,720...88,113,029
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 2:84,667,578...84,678,730
Ensembl chr 2:84,667,633...84,678,790
|
|
G |
Cdh2 |
cadherin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr18:8,146,971...8,366,037
Ensembl chr18:8,146,971...8,360,684
|
|
G |
Cldn11 |
claudin 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25911099 |
|
NCBI chr 2:115,823,541...115,836,846
Ensembl chr 2:115,823,538...115,836,846
|
|
G |
Cln6 |
CLN6, transmembrane ER protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23789114 |
|
NCBI chr 8:67,733,215...67,748,170
Ensembl chr 8:67,733,215...67,748,172
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23072421 |
|
NCBI chr 5:49,307,584...49,333,064
Ensembl chr 5:49,311,030...49,333,056
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27317300 |
|
NCBI chr 5:154,242,010...154,268,126
Ensembl chr 5:154,260,062...154,268,126
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17299831 |
|
NCBI chr 7:139,454,945...139,484,403
Ensembl chr 7:139,455,242...139,483,997
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27737899 |
|
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:104,147,205...104,166,389
Ensembl chr 1:104,147,206...104,166,367
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Ctu1 |
cytosolic thiouridylase subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr 1:99,599,608...99,605,412
Ensembl chr 1:99,599,620...99,605,412
|
|
G |
Ctu2 |
cytosolic thiouridylase subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr19:55,300,531...55,305,543
Ensembl chr19:55,300,395...55,305,702
|
|
G |
Dek |
DEK proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr17:17,965,872...17,987,836
Ensembl chr17:17,965,881...17,987,834
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29698737 |
|
NCBI chr 1:217,018,916...217,034,890
Ensembl chr 1:217,018,916...217,034,904
|
|
G |
Dmd |
dystrophin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22795790 PMID:26930420 PMID:30074247 |
|
NCBI chr X:51,149,358...53,519,271
Ensembl chr X:51,286,737...53,519,259
|
|
G |
Dstn |
destrin, actin depolymerizing factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr 3:138,024,508...138,051,304
Ensembl chr 3:138,024,508...138,051,298
|
|
G |
Eif2b1 |
eukaryotic translation initiation factor 2B subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr12:37,444,136...37,452,391
Ensembl chr12:37,444,072...37,465,398
|
|
G |
Eif3e |
eukaryotic translation initiation factor 3 subunit E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:82,997,694...83,037,231
|
|
G |
Elp3 |
elongator acetyltransferase complex subunit 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr15:48,942,866...49,005,074
Ensembl chr15:48,942,871...49,005,058
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22302033 |
|
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20962747 |
|
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21127298 |
|
NCBI chr16:81,824,610...81,834,923
Ensembl chr16:81,824,111...81,834,945
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22536412 PMID:26590112 |
|
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
|
|
G |
Fbl |
fibrillarin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:85,103,519...85,112,619
Ensembl chr 1:85,103,519...85,112,619
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:140,398,253...140,402,664
Ensembl chr 7:140,398,199...140,437,467
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:157,676,336...157,680,322
Ensembl chr 4:157,676,595...157,679,962
|
|
G |
Gar1 |
GAR1 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 2:235,250,453...235,258,464
Ensembl chr 2:235,250,453...235,257,731
|
|
G |
Gart |
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:31,780,477...31,805,728
Ensembl chr11:31,780,487...31,805,728
|
|
G |
Gata4 |
GATA binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr15:46,386,703...46,458,679
Ensembl chr15:46,386,712...46,432,965
|
|
G |
Gfap |
glial fibrillary acidic protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr10:90,990,762...90,999,435
Ensembl chr10:90,990,762...90,999,506
|
|
G |
Gli2 |
GLI family zinc finger 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27585885 |
|
NCBI chr13:34,829,021...35,049,172
Ensembl chr13:34,829,139...35,048,444
|
|
G |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:19,721,292...19,734,032
Ensembl chr15:19,721,293...19,733,967
|
|
G |
Golm1 |
golgi membrane protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr17:5,373,095...5,411,186
Ensembl chr17:5,382,034...5,409,038
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:90,063,411...90,091,287
Ensembl chr 1:90,063,411...90,091,287
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr 3:2,507,745...2,534,664
Ensembl chr 3:2,506,896...2,534,663
|
|
G |
Grwd1 |
glutamate-rich WD repeat containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:101,813,356...101,819,058
Ensembl chr 1:101,813,684...101,819,478
|
|
G |
H1f10 |
H1.10 linker histone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:119,889,016...119,892,661
Ensembl chr 4:119,889,371...119,889,949
|
|
G |
Hand2 |
heart and neural crest derivatives expressed 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr16:36,371,489...36,373,551
Ensembl chr16:36,371,489...36,373,546
|
|
G |
Hbb |
hemoglobin subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23975182 PMID:29255069 |
|
NCBI chr 1:168,971,269...168,972,680
Ensembl chr 1:168,971,274...168,972,725
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21937979 |
|
NCBI chr18:29,330,302...29,340,185
Ensembl chr18:29,329,764...29,340,403
|
|
G |
Hcn1 |
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19747469 |
|
NCBI chr 2:50,099,576...50,499,799
Ensembl chr 2:50,099,576...50,499,799
|
|
G |
Hells |
helicase, lymphoid specific |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:257,901,856...257,953,889
Ensembl chr 1:257,766,691...257,949,183 Ensembl chr 1:257,766,691...257,949,183
|
|
G |
Hk1 |
hexokinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:31,911,460...31,979,780
Ensembl chr20:31,912,262...31,956,649
|
|
G |
Hk2 |
hexokinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:113,559,396...113,609,897
Ensembl chr 4:113,559,427...113,610,243
|
|
G |
Hmgb2 |
high mobility group box 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr16:36,077,615...36,080,191
Ensembl chr16:36,077,617...36,080,191 Ensembl chr11:36,077,617...36,080,191
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:144,865,302...144,871,592
Ensembl chr 7:144,865,608...144,871,585
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27469509 |
|
NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16845661 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27580383 PMID:28411859 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Impdh2 |
inosine monophosphate dehydrogenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:117,346,983...117,351,619
Ensembl chr 8:117,347,029...117,351,610
|
|
G |
Ipo4 |
importin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:34,304,425...34,314,552
Ensembl chr15:34,304,425...34,314,345
|
|
G |
Ipo5 |
importin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:106,243,110...106,293,326
Ensembl chr15:106,257,650...106,292,112
|
|
G |
Irak4 |
interleukin-1 receptor-associated kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28003376 |
|
NCBI chr 7:135,803,723...135,831,006
Ensembl chr 7:135,803,698...135,832,652
|
|
G |
Kl |
Klotho |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25550330 |
|
NCBI chr12:942,974...987,206
Ensembl chr12:943,006...987,551
|
|
G |
Kng2 |
kininogen 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30685357 |
|
NCBI chr11:81,509,185...81,516,759
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:95,200,029...95,212,111
Ensembl chr10:95,200,030...95,212,111
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26390243 PMID:27588471 |
|
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
|
|
G |
Ldha |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:102,900,288...102,909,713
Ensembl chr 1:102,900,286...102,909,707
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27811057 |
|
NCBI chr 2:236,232,115...236,345,061
Ensembl chr 2:236,233,239...236,345,056
|
|
G |
Lmnb1 |
lamin B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr18:51,785,111...51,822,264
Ensembl chr18:51,785,111...51,822,264
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr10:35,333,859...35,374,364
Ensembl chr10:35,333,859...35,374,355
|
|
G |
Mapt |
microtubule-associated protein tau |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24556215 |
|
NCBI chr10:92,289,002...92,386,517
Ensembl chr10:92,288,910...92,386,517
|
|
G |
Mecp2 |
methyl CpG binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28592917 |
|
NCBI chr X:156,650,389...156,713,813
Ensembl chr X:156,655,960...156,705,233
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21051829 |
|
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Mre11 |
MRE11 homolog, double strand break repair nuclease |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:13,304,355...13,350,329
Ensembl chr 8:13,305,152...13,352,489
|
|
G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:109,658,032...109,662,535
Ensembl chr10:109,658,032...109,662,535
|
|
G |
Mrps5 |
mitochondrial ribosomal protein S5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:120,165,953...120,182,536
Ensembl chr 3:120,165,913...120,182,536
|
|
G |
Mybpc3 |
myosin binding protein C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25566086 |
|
NCBI chr 3:79,940,509...79,958,731
Ensembl chr 3:79,940,561...79,958,730
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Naa10 |
N(alpha)-acetyltransferase 10, NatA catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:156,863,655...156,868,950
Ensembl chr X:156,863,754...156,868,950
|
|
G |
Ncl |
nucleolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:93,369,119...93,377,643
Ensembl chr 9:93,368,932...93,377,643
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29255069 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nop56 |
NOP56 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:122,803,726...122,808,564
Ensembl chr 3:122,803,772...122,808,558
|
|
G |
Nop58 |
NOP58 ribonucleoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:66,495,881...66,520,521
Ensembl chr 9:66,495,832...66,519,788
|
|
G |
Nphp3 |
nephrocystin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12089381 |
|
NCBI chr 8:112,526,553...112,575,745
Ensembl chr 8:112,526,553...112,575,745
|
|
G |
Npm1 |
nucleophosmin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:18,080,949...18,091,062
Ensembl chr10:18,080,950...18,090,950
|
|
G |
Npm3 |
nucleophosmin/nucleoplasmin, 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:265,504,105...265,506,080
Ensembl chr 1:265,504,575...265,506,046
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr 5:164,796,176...164,797,538
Ensembl chr 5:164,796,185...164,797,531
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29142166 PMID:32062620 |
|
NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
|
|
G |
Nudt21 |
nudix hydrolase 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr19:11,451,366...11,470,637
Ensembl chr19:11,450,760...11,467,644
|
|
G |
P2rx7 |
purinergic receptor P2X 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27466191 |
|
NCBI chr12:39,353,613...39,396,042
Ensembl chr12:39,353,613...39,396,042
|
|
G |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:140,978,893...140,994,732
Ensembl chr 5:140,979,435...140,994,732
|
|
G |
Pcbd1 |
pterin-4 alpha-carbinolamine dehydratase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:30,689,690...30,696,465
Ensembl chr20:30,690,810...30,696,476
|
|
G |
Pde6b |
phosphodiesterase 6B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17213800 |
|
NCBI chr14:2,328,690...2,371,913
Ensembl chr14:2,328,750...2,371,883
|
|
G |
Pign |
phosphatidylinositol glycan anchor biosynthesis, class N |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr13:25,510,593...25,662,943
Ensembl chr13:25,513,892...25,652,473
|
|
G |
Pim1 |
Pim-1 proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25812446 |
|
NCBI chr20:8,165,423...8,169,557
Ensembl chr20:8,165,307...8,169,555
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25877301 |
|
NCBI chr10:13,914,057...13,962,008
Ensembl chr10:13,915,214...13,962,008
|
|
G |
Polr1d |
RNA polymerase I and III subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr12:9,693,828...9,727,416
Ensembl chr12:9,693,779...9,727,489
|
|
G |
Ppan |
peter pan homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:21,905,865...21,909,845
Ensembl chr 8:21,905,865...21,909,842
|
|
G |
Prkcg |
protein kinase C, gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr 1:64,407,098...64,433,698
Ensembl chr 1:64,407,114...64,433,636
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15882845 |
|
NCBI chr 1:48,880,015...50,069,998
|
|
G |
Psat1 |
phosphoserine aminotransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:233,124,089...233,145,941
Ensembl chr 1:233,124,092...233,145,941
|
|
G |
Psen1 |
presenilin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16651627 PMID:27567873 |
|
NCBI chr 6:107,169,514...107,221,000
Ensembl chr 6:107,169,528...107,216,798
|
|
G |
Pth |
parathyroid hormone |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30639440 |
|
NCBI chr 1:178,215,829...178,218,761
Ensembl chr 1:178,215,829...178,218,761
|
|
G |
Rangrf |
RAN guanine nucleotide release factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:55,559,049...55,560,420
Ensembl chr10:55,559,041...55,560,422
|
|
G |
Rcl1 |
RNA terminal phosphate cyclase-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:247,228,012...247,272,369
Ensembl chr 1:247,228,061...247,305,693
|
|
G |
Rfc4 |
replication factor C subunit 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:81,358,592...81,373,044
Ensembl chr11:81,358,592...81,373,043
|
|
G |
Rhoa |
ras homolog family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25783350 |
|
NCBI chr 8:117,082,440...117,116,244
Ensembl chr 8:117,106,576...117,116,167
|
|
G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr 6:42,180,864...42,289,910
Ensembl chr 6:42,180,894...42,289,908
|
|
G |
Rpl10a |
ribosomal protein L10A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:7,908,309...7,910,867
Ensembl chr20:7,908,304...7,910,867
|
|
G |
Rpl13a |
ribosomal protein L13A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:101,120,325...101,123,401
Ensembl chr 1:101,120,325...101,123,402
|
|
G |
Rpl27a |
ribosomal protein L27a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:174,132,798...174,135,816
Ensembl chr 1:174,132,798...174,135,816
|
|
G |
Rpl36a |
ribosomal protein L36a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:105,402,867...105,405,580
Ensembl chr X:105,402,867...105,405,580
|
|
G |
Rpsa |
ribosomal protein SA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:128,806,053...128,809,987
Ensembl chr 8:128,806,129...128,809,986
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:167,538,387...167,562,688
Ensembl chr 1:167,538,263...167,562,688
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515
|
|
G |
Rrs1 |
ribosome biogenesis regulator 1 homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:9,430,710...9,432,343
Ensembl chr 5:9,430,728...9,432,343
|
|
G |
S100a10 |
S100 calcium binding protein A10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21682946 |
|
NCBI chr 2:193,892,589...193,901,236
Ensembl chr 2:193,892,589...193,901,236
|
|
G |
S100b |
S100 calcium binding protein B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12888777 |
|
NCBI chr20:13,130,633...13,142,856
Ensembl chr20:13,130,636...13,142,856
|
|
G |
Satb1 |
SATB homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:2,181,135...2,277,949
Ensembl chr 9:2,190,915...2,274,629
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21051829 |
|
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Sfxn1 |
sideroflexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr17:11,046,588...11,082,219
Ensembl chr17:11,045,761...11,082,047
|
|
G |
Sh3pxd2b |
SH3 and PX domains 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28719234 |
|
NCBI chr10:17,209,152...17,296,449
Ensembl chr10:17,209,212...17,291,876
|
|
G |
Shmt1 |
serine hydroxymethyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:47,030,813...47,059,216
Ensembl chr10:47,031,050...47,059,216
|
|
G |
Slc15a2 |
solute carrier family 15 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr11:66,932,664...66,961,708
Ensembl chr11:66,932,614...66,961,713
|
|
G |
Slc19a1 |
solute carrier family 19 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr20:12,334,675...12,354,517
Ensembl chr20:12,334,676...12,352,377
|
|
G |
Slc29a1 |
solute carrier family 29 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27567601 |
|
NCBI chr 9:17,784,468...17,799,008
Ensembl chr 9:17,784,468...17,799,005
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr14:20,476,258...20,817,042
Ensembl chr14:20,479,323...20,920,286
|
|
G |
Slc4a7 |
solute carrier family 4 member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr15:11,832,611...11,912,923
Ensembl chr15:11,836,286...11,912,916
|
|
G |
Smarcc1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 8:118,206,678...118,326,264
Ensembl chr 8:118,206,698...118,325,537
|
|
G |
Snca |
synuclein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21892157 PMID:26075822 |
|
NCBI chr 4:90,782,412...90,883,236
Ensembl chr 4:90,782,374...90,882,285
|
|
G |
Snrpg |
small nuclear ribonucleoprotein polypeptide G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:118,167,267...118,174,846
Ensembl chr 4:118,167,294...118,174,842
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12586733 PMID:19227972 PMID:20177826 PMID:21867702 PMID:23583883 PMID:24885036 |
|
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Srm |
spermidine synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 5:165,405,168...165,408,325
Ensembl chr 5:165,405,168...165,408,320
|
|
G |
Srr |
serine racemase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:61,756,138...61,772,327
Ensembl chr10:61,756,138...61,772,293
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25812446 |
|
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Stk39 |
serine threonine kinase 39 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:54,359,449...54,625,702
Ensembl chr 3:54,359,451...54,625,414
|
|
G |
Strbp |
spermatid perinuclear RNA binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:21,817,680...21,956,988
Ensembl chr 3:21,828,298...21,904,270
|
|
G |
Suclg2 |
succinate-CoA ligase GDP-forming subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:127,552,100...127,824,970
Ensembl chr 4:127,552,101...127,824,970
|
|
G |
Tbx20 |
T-box transcription factor 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr 8:25,849,394...25,904,570
Ensembl chr 8:25,850,962...25,904,570
|
|
G |
Tcf7l2 |
transcription factor 7 like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29394407 |
|
NCBI chr 1:276,686,911...276,730,517
Ensembl chr 1:276,659,542...276,730,514 Ensembl chr 1:276,659,542...276,730,514
|
|
G |
Tfam |
transcription factor A, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28595911 |
|
NCBI chr20:18,594,057...18,606,106
Ensembl chr20:18,594,037...18,606,151
|
|
G |
Tg |
thyroglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30373627 |
|
NCBI chr 7:107,467,260...107,652,897
Ensembl chr 7:107,467,260...107,652,899
|
|
G |
Timm10 |
translocase of inner mitochondrial membrane 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 3:72,226,563...72,230,087
Ensembl chr 3:72,226,613...72,230,084
|
|
G |
Timm8a1 |
translocase of inner mitochondrial membrane 8A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr X:105,351,714...105,355,722
Ensembl chr X:105,352,402...105,355,716
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21051829 |
|
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
|
|
G |
Tk1 |
thymidine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:106,817,556...106,828,888
Ensembl chr10:106,817,601...106,828,884
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27093858 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tomm40 |
translocase of outer mitochondrial membrane 40 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 1:80,617,749...80,630,253
Ensembl chr 1:80,618,154...80,630,038
|
|
G |
Top2a |
DNA topoisomerase II alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23873029 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 4:157,328,375...157,331,905
Ensembl chr 4:157,328,379...157,331,905
|
|
G |
Tyms |
thymidylate synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564
|
|
G |
Uck2 |
uridine-cytidine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr13:85,376,716...85,443,976
Ensembl chr13:85,376,716...85,443,976
|
|
G |
Vcp |
valosin-containing protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25884947 |
|
NCBI chr 5:58,426,548...58,445,953
Ensembl chr 5:58,426,549...58,445,953
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16831193 |
|
NCBI chr17:80,882,715...80,891,200
Ensembl chr17:80,882,666...80,891,212
|
|
G |
Wnt11 |
Wnt family member 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25783350 |
|
NCBI chr 1:163,794,136...163,813,756
Ensembl chr 1:163,797,660...163,813,756
|
|
G |
Xrcc5 |
X-ray repair cross complementing 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 9:79,659,275...79,748,050
Ensembl chr 9:79,659,251...79,748,078
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27602772 |
|
NCBI chr 7:123,259,881...123,280,613
Ensembl chr 7:123,259,761...123,280,612
|
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
protein:increased expression:plasmacytoid dendritic cell |
RGD |
PMID:20702728 |
RGD:5490530 |
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
|
RGD |
PMID:27980102 |
RGD:14995459 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:15368307 |
RGD:5688161 |
NCBI chr 8:132,996,646...133,002,201
Ensembl chr 8:132,996,649...133,002,201
|
|
G |
Cp |
ceruloplasmin |
|
IEP |
protein:increased expression:lymph, plasma |
RGD |
PMID:19526092 |
RGD:2314684 |
NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:8821709 |
RGD:2303519 |
NCBI chr 9:74,113,437...74,236,274
Ensembl chr 9:74,124,016...74,236,274
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:18642776 |
RGD:2307010 |
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:18642776 |
RGD:2307010 |
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:21695461 |
RGD:14402037 |
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18559427 |
|
NCBI chr 3:11,414,189...11,417,534
Ensembl chr 3:11,414,186...11,417,546
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:8781331 |
RGD:2317559 |
NCBI chr 4:44,747,467...44,854,628
Ensembl chr 4:44,774,741...44,852,665
|
|
G |
Otc |
ornithine transcarbamylase |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:8821709 |
RGD:2303519 |
NCBI chr X:13,524,804...13,601,074
Ensembl chr X:13,524,607...13,601,069
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
|
IEP |
|
RGD |
PMID:12127424 |
RGD:2303132 |
NCBI chr 4:175,814,118...175,881,775
Ensembl chr 4:175,814,118...175,881,768
|
|
G |
Tff3 |
trefoil factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18559427 |
|
NCBI chr20:9,850,800...9,855,481
Ensembl chr20:9,850,803...9,855,481
|
|
G |
Ubd |
ubiquitin D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18559427 |
|
NCBI chr20:1,876,175...1,878,126
Ensembl chr20:1,876,173...1,897,814
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:19222997 |
RGD:5685610 |
NCBI chr 1:42,169,307...42,177,582
Ensembl chr 1:42,169,501...42,177,582
|
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
|
|
G |
Actb |
actin, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841
|
|
G |
Actg1 |
actin, gamma 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr10:109,518,429...109,521,288
Ensembl chr 3:75,643,054...75,644,954 Ensembl chr10:75,643,054...75,644,954
|
|
G |
Actn4 |
actinin alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 1:87,078,012...87,147,347
Ensembl chr 1:87,078,020...87,147,333
|
|
G |
Adcy5 |
adenylate cyclase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr11:68,695,839...68,842,452
Ensembl chr11:68,695,839...68,842,320
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr11:50,780,735...50,985,083
Ensembl chr11:50,781,127...50,985,083
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:16316942 PMID:22248470 |
|
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22248470 |
|
NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
|
|
G |
Anxa4 |
annexin A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9111214 |
|
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
|
|
G |
Aqp1 |
aquaporin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360
|
|
G |
Areg |
amphiregulin |
|
IEP |
mRNA:increased expression:mammary gland |
RGD |
PMID:18421211 |
RGD:2292665 |
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
|
|
G |
Atp5if1 |
ATP synthase inhibitory factor subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:16316942 |
|
NCBI chr 5:150,719,570...150,723,287
Ensembl chr 5:150,719,569...150,723,321
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 2:77,586,424...77,632,626
Ensembl chr 2:77,586,424...77,632,628
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12203372 |
|
NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 5:157,642,742...157,742,487
Ensembl chr 5:157,642,751...157,742,478
|
|
G |
Cask |
calcium/calmodulin dependent serine protein kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr X:9,815,652...10,156,155
Ensembl chr X:9,815,652...10,156,155
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:14522882 PMID:16316942 PMID:17173897 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccnh |
cyclin H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12606953 |
|
NCBI chr 2:13,593,100...13,613,910
Ensembl chr 2:13,593,100...13,613,910
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:19787232 |
RGD:6893387 |
NCBI chr 8:133,026,539...133,040,999
Ensembl chr 8:133,029,625...133,040,997
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:15922965 |
RGD:8547789 |
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
G |
Cdc42 |
cell division cycle 42 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 5:155,690,267...155,728,385
Ensembl chr 5:155,691,390...155,728,300
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:14522882 |
|
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
onset |
ISO |
|
RGD |
PMID:11103935 |
RGD:8662404 |
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr14:9,396,511...9,456,964
Ensembl chr14:9,396,512...9,456,990
|
|
G |
Cnn3 |
calponin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 2:225,005,069...225,036,179
Ensembl chr 2:225,005,019...225,036,188
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 3:6,430,180...6,581,010
Ensembl chr 3:6,430,201...6,578,882
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
protein:increased expression:mammary gland, cytoplasm CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18424824, PMID:6337293 |
RGD:2289734 |
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
|
|
G |
Coro1a |
coronin 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21489049 |
|
NCBI chr 1:198,123,883...198,128,890
Ensembl chr 1:198,123,884...198,128,857
|
|
G |
Csn2 |
casein beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9879772 PMID:16316942 |
|
NCBI chr14:21,972,274...21,979,511
Ensembl chr14:21,972,274...21,979,510
|
|
G |
Csn3 |
casein kappa |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr14:21,803,738...21,810,291
Ensembl chr14:21,803,735...21,810,314
|
|
G |
Dbi |
diazepam binding inhibitor, acyl-CoA binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr13:36,147,667...36,156,076
Ensembl chr13:36,117,119...36,174,908
|
|
G |
Des |
desmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 9:82,556,574...82,564,288
Ensembl chr 9:82,556,573...82,564,294
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 8:85,838,594...85,841,816
Ensembl chr 8:85,838,869...85,840,818
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr14:113,202,382...113,294,993
Ensembl chr14:113,202,419...113,295,014
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8603490 |
|
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr10:56,527,075...56,531,615
Ensembl chr10:56,527,085...56,531,483
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
|
|
G |
Epcam |
epithelial cell adhesion molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 6:11,282,194...11,308,870
Ensembl chr 6:11,281,964...11,298,216
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8603490 |
|
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15637090 PMID:17173897 |
|
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15637090 |
|
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Ezr |
ezrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 1:47,287,872...47,331,412
Ensembl chr 1:47,287,874...47,331,412
|
|
G |
F11r |
F11 receptor |
|
ISO |
|
RGD |
PMID:21695058 |
RGD:7488916 |
NCBI chr13:89,826,272...89,850,151
Ensembl chr13:89,826,254...89,850,612
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
|
RGD |
PMID:22407271 |
RGD:8554853 |
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Furin |
furin (paired basic amino acid cleaving enzyme) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:16316942 |
|
NCBI chr 1:142,185,092...142,198,167
Ensembl chr 1:142,185,094...142,197,182
|
|
G |
G0s2 |
G0/G1switch 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr13:112,004,140...112,005,052
Ensembl chr13:112,004,140...112,005,052
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr17:72,419,752...72,452,043
Ensembl chr17:72,429,618...72,450,681
|
|
G |
Gatm |
glycine amidinotransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 3:114,711,570...114,728,155
Ensembl chr 3:114,711,562...114,728,410
|
|
G |
Gda |
guanine deaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 1:238,982,542...239,057,663
Ensembl chr 1:238,982,392...239,057,732
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 8:116,370,730...116,391,337
Ensembl chr 8:116,370,744...116,391,307
|
|
G |
Gss |
glutathione synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 3:151,076,254...151,106,557
Ensembl chr 3:151,076,254...151,106,557
|
|
G |
H3f3b |
H3.3 histone B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr10:104,573,666...104,575,890
Ensembl chr10:104,573,664...104,575,890
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr10:15,589,364...15,590,207
Ensembl chr10:15,589,364...15,590,220
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 7:144,865,302...144,871,592
Ensembl chr 7:144,865,608...144,871,585
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8185828 |
|
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
|
|
G |
Id3 |
inhibitor of DNA binding 3, HLH protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 5:154,489,603...154,491,172
Ensembl chr 5:154,489,590...154,491,223
|
|
G |
Id4 |
inhibitor of DNA binding 4, HLH protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14633621 |
|
NCBI chr17:16,692,557...16,695,126
Ensembl chr17:16,692,557...16,695,126
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
IEP |
mRNA:increased expression:mammary gland |
RGD |
PMID:18421211 |
RGD:2292665 |
NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12606953 |
|
NCBI chr 2:44,279,199...44,319,427
Ensembl chr 2:44,289,393...44,314,944
|
|
G |
Insig1 |
insulin induced gene 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 4:342,302...350,515
Ensembl chr 4:342,302...350,515
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
|
RGD |
PMID:19888452 |
RGD:5684399 |
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 7:42,269,784...42,351,054
Ensembl chr 7:42,269,784...42,351,054
|
|
G |
Kng2 |
kininogen 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22248470 |
|
NCBI chr11:81,509,185...81,516,759
|
|
G |
Krt5 |
keratin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 7:143,320,142...143,324,536
Ensembl chr 7:143,316,920...143,453,546
|
|
G |
Krt71 |
keratin 71 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 7:143,345,201...143,371,346
Ensembl chr 7:143,345,201...143,353,925
|
|
G |
Lgals7 |
galectin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 1:87,044,823...87,047,223
Ensembl chr 1:87,045,335...87,047,223
|
|
G |
Lin7a |
lin-7 homolog A, crumbs cell polarity complex component |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 7:49,429,613...49,627,835
Ensembl chr 7:49,385,705...49,656,856
|
|
G |
Lpl |
lipoprotein lipase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
|
|
G |
Lsr |
lipolysis stimulated lipoprotein receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:16316942 |
|
NCBI chr 1:89,383,515...89,399,041
Ensembl chr 1:89,383,519...89,399,041
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
ISO |
|
RGD |
PMID:17016428 |
RGD:7495832 |
NCBI chr10:98,707,160...98,823,054
Ensembl chr10:98,706,960...98,823,287
|
|
G |
Mdh2 |
malate dehydrogenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr12:23,941,451...23,954,406
Ensembl chr12:23,941,448...23,954,431
|
|
G |
Mgp |
matrix Gla protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:16316942 |
|
NCBI chr 4:170,856,783...170,860,105
Ensembl chr 4:170,856,751...170,860,225
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr20:13,715,219...13,732,980
Ensembl chr20:13,732,198...13,732,859
|
|
G |
Mir100 |
microRNA 100 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24447120 |
|
NCBI chr 8:45,746,948...45,747,027
Ensembl chr 8:45,746,948...45,747,027
|
|
G |
Mir10a |
microRNA 10a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24447120 |
|
NCBI chr10:84,165,950...84,166,059
Ensembl chr10:84,165,950...84,166,059
|
|
G |
Mir10b |
microRNA 10b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24447120 |
|
NCBI chr 3:61,647,978...61,648,086
Ensembl chr 3:61,647,978...61,648,086
|
|
G |
Mir145 |
microRNA 145 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24447120 |
|
NCBI chr18:56,969,907...56,969,994
Ensembl chr18:56,969,907...56,969,994
|
|
G |
Mir205 |
microRNA 205 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24447120 |
|
NCBI chr13:112,233,283...112,233,390
Ensembl chr13:112,233,283...112,233,390
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
ISO |
|
RGD |
PMID:23714264 |
RGD:8547831 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Mpzl1 |
myelin protein zero-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr13:83,805,244...83,842,074
Ensembl chr13:83,805,244...83,842,051
|
|
G |
Mrc2 |
mannose receptor, C type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr10:93,520,272...93,581,599
Ensembl chr10:93,520,132...93,581,296
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Ndn |
necdin, MAGE family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21489049 |
|
NCBI chr 1:122,981,755...122,983,354
Ensembl chr 1:122,981,755...122,983,351
|
|
G |
Notch4 |
notch receptor 4 |
|
ISO |
DNA, mRNA:mutation, alternative form |
RGD |
PMID:8030284 |
RGD:2299155 |
NCBI chr20:4,329,794...4,353,868
Ensembl chr20:4,329,811...4,353,785
|
|
G |
Nsmf |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 3:2,262,173...2,270,996
Ensembl chr 3:2,262,253...2,270,995
|
|
G |
Padi4 |
peptidyl arginine deiminase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 5:159,260,675...159,293,906
Ensembl chr 5:159,260,675...159,293,673
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:16316942 |
|
NCBI chr12:17,734,141...17,756,186
Ensembl chr12:17,734,133...17,755,285
|
|
G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr12:45,026,948...45,031,148
Ensembl chr12:45,026,886...45,031,145
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 1:261,158,204...261,165,814
Ensembl chr 1:261,158,261...261,165,808
|
|
G |
Pgr |
progesterone receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15637090 |
|
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
|
|
G |
Phb |
prohibitin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12606953 |
|
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
|
|
G |
Pkm |
pyruvate kinase M1/2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 8:64,480,963...64,502,957
Ensembl chr 8:64,481,172...64,502,722
|
|
G |
Plk2 |
polo-like kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 2:41,911,143...41,916,901
Ensembl chr 2:41,911,131...41,916,901
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11137312 |
|
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Prdx2 |
peroxiredoxin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr19:26,084,816...26,090,095
Ensembl chr19:26,084,903...26,090,094
|
|
G |
Prl |
prolactin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:6280079 PMID:16316942 |
|
NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
|
|
G |
Prlr |
prolactin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 PMID:17173897 |
|
NCBI chr 2:60,131,410...60,325,686
Ensembl chr 2:60,131,776...60,325,692
|
|
G |
Psma4 |
proteasome 20S subunit alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 8:59,532,456...59,539,916
Ensembl chr 8:59,532,389...59,539,920
|
|
G |
Psme1 |
proteasome activator subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr15:34,256,071...34,258,947
Ensembl chr15:34,256,071...34,258,947
|
|
G |
Ptbp1 |
polypyrimidine tract binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 7:12,663,965...12,673,723
Ensembl chr 7:12,663,965...12,673,718
|
|
G |
Ptger1 |
prostaglandin E receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11751431 |
|
NCBI chr19:24,799,422...24,803,373
Ensembl chr19:24,800,072...24,803,373
|
|
G |
Ptn |
pleiotrophin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 4:64,239,156...64,330,996
Ensembl chr 4:64,239,158...64,330,996
|
|
G |
Ran |
RAN, member RAS oncogene family |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:16316942 |
|
NCBI chr12:31,319,556...31,324,105
Ensembl chr12:31,320,624...31,323,810
|
|
G |
Rasa1 |
RAS p21 protein activator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12606953 |
|
NCBI chr 2:13,617,021...13,696,531
Ensembl chr 2:13,616,822...13,696,426
|
|
G |
Rasgrf2 |
RAS protein-specific guanine nucleotide-releasing factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12606953 |
|
NCBI chr 2:21,460,041...21,698,937
|
|
G |
Rassf1 |
Ras association domain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20008439 |
|
NCBI chr 8:116,307,149...116,318,289
Ensembl chr 8:116,307,141...116,318,289
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14522882, PMID:21364977 |
RGD:8547983 |
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Rbp1 |
retinol binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 8:106,449,321...106,470,842
Ensembl chr 8:106,449,321...106,470,842
|
|
G |
Rbp4 |
retinol binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 1:256,806,476...256,813,678
Ensembl chr 1:256,806,472...256,813,711
|
|
G |
Rcn1 |
reticulocalbin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 3:95,404,863...95,419,110
Ensembl chr 3:95,406,284...95,418,679
|
|
G |
Rel |
REL proto-oncogene, NF-kB subunit |
|
ISO |
|
RGD |
PMID:12897145 |
RGD:2300264 |
NCBI chr14:108,490,794...108,517,582
Ensembl chr14:108,491,069...108,509,892
|
|
G |
Relb |
RELB proto-oncogene, NF-kB subunit |
|
ISO |
|
RGD |
PMID:12897145 |
RGD:2300264 |
NCBI chr 1:80,517,081...80,545,019
Ensembl chr 1:80,517,411...80,544,825
|
|
G |
Rpl3 |
ribosomal protein L3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 7:121,297,365...121,302,739
Ensembl chr 7:121,297,355...121,311,565
|
|
G |
Rpl6 |
ribosomal protein L6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr12:40,877,578...40,882,032
Ensembl chr12:40,877,613...40,881,124
|
|
G |
Rps14 |
ribosomal protein S14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr18:56,042,532...56,047,316
Ensembl chr18:56,044,369...56,047,316
|
|
G |
S100a6 |
S100 calcium binding protein A6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 2:190,007,013...190,008,512
Ensembl chr 2:190,007,216...190,008,511
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22248470 |
|
NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
|
|
G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 2:218,654,406...218,658,761
Ensembl chr 2:218,654,554...218,658,761
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr12:36,694,952...36,761,445
Ensembl chr12:36,694,960...36,761,455
|
|
G |
Scd |
stearoyl-CoA desaturase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:16316942 |
|
NCBI chr 1:264,159,966...264,173,061
Ensembl chr 1:264,160,129...264,172,729
|
|
G |
Selenop |
selenoprotein P |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:16316942 |
|
NCBI chr 2:53,105,912...53,116,198
Ensembl chr 2:53,109,684...53,114,858
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 1:24,185,451...24,302,309
Ensembl chr 1:24,185,435...24,302,298
|
|
G |
Slc12a2 |
solute carrier family 12 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr18:52,917,124...52,985,281
Ensembl chr18:52,917,124...52,985,261
|
|
G |
Slc25a10 |
solute carrier family 25 member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr10:109,665,682...109,674,782
Ensembl chr10:109,665,682...109,673,143
|
|
G |
Sncg |
synuclein, gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr16:10,722,110...10,726,648
Ensembl chr16:10,722,106...10,726,707
|
|
G |
Snrpd3 |
small nuclear ribonucleoprotein D3 polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr20:14,080,562...14,095,644
Ensembl chr20:14,080,565...14,095,181
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
IEP |
protein:decreased expression:mammary gland (rat) |
RGD |
PMID:17157473 |
RGD:8657018 |
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr10:101,288,528...101,294,030
Ensembl chr10:101,288,489...101,293,379
|
|
G |
Spint2 |
serine peptidase inhibitor, Kunitz type, 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 1:87,199,373...87,221,826
Ensembl chr 1:87,199,313...87,221,892
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr10:105,792,779...105,795,986
Ensembl chr10:105,792,779...105,795,958
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:15609129 PMID:16316942 PMID:17173897 PMID:20235097 |
|
NCBI chr10:88,764,732...88,789,060
Ensembl chr10:88,764,732...88,789,057
|
|
G |
Stmn1 |
stathmin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 5:152,680,412...152,686,807
Ensembl chr 5:152,680,407...152,686,806
|
|
G |
Tf |
transferrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9879772 PMID:16316942 |
|
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
|
|
G |
Tgfa |
transforming growth factor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8603490 |
|
NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
|
|
G |
Thrsp |
thyroid hormone responsive |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 1:162,381,251...162,385,575
Ensembl chr 1:162,381,253...162,385,575
|
|
G |
Tkt |
transketolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr16:6,609,670...6,634,608
Ensembl chr16:6,609,668...6,634,595
|
|
G |
Tle4 |
TLE family member 4, transcriptional corepressor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 1:231,394,606...231,531,396
Ensembl chr 1:231,393,379...231,530,786
|
|
G |
Tmem37 |
transmembrane protein 37 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21489049 |
|
NCBI chr13:36,094,665...36,101,443
Ensembl chr13:36,094,520...36,101,411
|
|
G |
Tp53i3 |
tumor protein p53 inducible protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21489049 |
|
NCBI chr13:75,101,759...75,145,967
Ensembl chr13:75,105,615...75,143,441
|
|
G |
Tpm3 |
tropomyosin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 PMID:16316942 |
|
NCBI chr 2:189,423,534...189,451,340
Ensembl chr 2:189,423,559...189,451,029
|
|
G |
Trps1 |
transcriptional repressor GATA binding 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 7:90,085,895...90,320,430
Ensembl chr 7:90,090,828...90,318,221
|
|
G |
Tsc22d1 |
TSC22 domain family, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr15:58,554,358...58,658,156
Ensembl chr15:58,554,374...58,658,153
|
|
G |
Tubb2b |
tubulin, beta 2B class IIb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr17:31,441,640...31,444,687
Ensembl chr17:31,441,630...31,482,759
|
|
G |
Ube2i |
ubiquitin-conjugating enzyme E2I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr10:14,618,615...14,639,274
Ensembl chr10:14,620,531...14,630,151
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 1:165,506,375...165,512,744
Ensembl chr 1:165,506,361...165,512,744
|
|
G |
Vamp8 |
vesicle-associated membrane protein 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16316942 |
|
NCBI chr 4:100,250,301...100,252,756
Ensembl chr 4:100,250,301...100,252,755
|
|
G |
Wnt1 |
Wnt family member 1 |
|
ISO |
|
RGD |
PMID:10918574 |
RGD:2298804 |
NCBI chr 7:140,464,999...140,469,046
Ensembl chr 7:140,464,999...140,469,046
|
|
G |
Wnt3 |
Wnt family member 3 |
|
ISO |
|
RGD |
PMID:10918574 |
RGD:2298804 |
NCBI chr10:91,830,709...91,874,907
Ensembl chr10:91,830,654...91,874,793
|
|
G |
Wnt6 |
Wnt family member 6 |
|
ISO |
|
RGD |
PMID:18649356 |
RGD:2298845 |
NCBI chr 9:82,033,543...82,047,172
Ensembl chr 9:82,033,543...82,047,166
|
|
G |
Xdh |
xanthine dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
|
|
G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12376462 |
|
NCBI chr 7:75,573,553...75,598,295
Ensembl chr 7:75,574,967...75,597,276
|
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
IEP |
mRNA, protein:increased expression:blood vessel endothelial cell |
RGD |
PMID:15710456 |
RGD:2307183 |
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19741601 |
RGD:8661685 |
|
|
G |
Cd209 |
CD209 molecule |
treatment |
ISO |
|
RGD |
PMID:32391004 |
RGD:39939012 |
NCBI chr12:2,406,879...2,413,324
Ensembl chr12:2,406,879...2,413,324
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
mRNA:decreased expression:placenta: |
RGD |
PMID:21923716 |
RGD:38501105 |
NCBI chr X:15,753,175...15,768,648
Ensembl chr X:15,753,175...15,768,522
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
|
ISO |
|
RGD |
PMID:8881756 |
RGD:12910478 |
NCBI chr 9:61,680,529...61,691,202
Ensembl chr 9:61,680,530...61,690,956
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
|
RGD |
PMID:31231617 |
RGD:39939039 |
NCBI chr16:72,216,326...72,228,098
Ensembl chr16:72,216,326...72,228,098
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
mRNA,protein:increased expression:placenta: |
RGD |
PMID:21923716 |
RGD:38501105 |
NCBI chr 9:26,841,299...26,844,786
Ensembl chr 9:26,841,299...26,844,786
|
|
G |
Il23a |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:15265921 |
RGD:39457943 |
NCBI chr 7:2,710,609...2,712,723
Ensembl chr 7:2,710,609...2,712,723
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
mRNA:increased expression:placenta: |
RGD |
PMID:21923716 |
RGD:38501105 |
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
|
RGD |
PMID:18316222 |
RGD:5490254 |
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
|
|
G |
Rorc |
RAR-related orphan receptor C |
|
ISO |
mRNA:increased expression:placenta: |
RGD |
PMID:21923716 |
RGD:38501105 |
NCBI chr 2:195,612,471...195,636,797
Ensembl chr 2:195,617,021...195,637,630
|
|
G |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
severity |
ISO |
|
RGD |
PMID:31416833 |
RGD:39128220 |
NCBI chr18:28,529,537...28,535,828
Ensembl chr18:28,529,576...28,535,828
|
|
|
G |
Cd40 |
CD40 molecule |
severity |
ISO |
|
RGD |
PMID:21360722 |
RGD:5490303 |
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
G |
Rnasel |
ribonuclease L |
disease_progression |
ISO |
associated with Coronaviridae Infections associated with Middle East respiratory syndrome |
RGD |
PMID:28003490, PMID:27025250 |
RGD:40902624, RGD:40902807 |
NCBI chr13:71,188,712...71,202,636
Ensembl chr13:71,192,142...71,202,625
|
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
severity treatment |
ISO |
human protein in a mouse model |
RGD |
PMID:24800825, PMID:24800825 |
RGD:32716391, RGD:32716391 |
NCBI chr X:32,050,734...32,095,860
Ensembl chr X:32,049,931...32,096,016
|
|
G |
Mx2 |
MX dynamin like GTPase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:178595 |
|
NCBI chr11:38,035,306...38,066,185
Ensembl chr11:38,035,450...38,059,950
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:18613795 |
RGD:5135502 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
protein:decreased expression:serum (human) |
RGD |
PMID:25539588 |
RGD:11541121 |
NCBI chr10:94,850,971...94,913,202
|
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
|
IEP |
mRNA, protein:decreased expression:cerebellum, Purkinje cell |
RGD |
PMID:17182680 |
RGD:2301132 |
NCBI chr10:65,586,504...65,590,093
Ensembl chr10:65,586,504...65,590,126
|
|
G |
Atf4 |
activating transcription factor 4 |
|
IEP |
protein:increased expression:cerebellum |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr 7:121,480,723...121,482,781
Ensembl chr 7:121,480,723...121,482,772
|
|
G |
Atf6 |
activating transcription factor 6 |
|
IEP |
protein:increased expression:cerebellum, hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr13:89,053,457...89,242,531
Ensembl chr13:89,055,983...89,242,443
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
|
IEP |
|
RGD |
PMID:16612977 |
RGD:2289373 |
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:12053272 |
RGD:4891998 |
NCBI chr19:10,644,267...10,654,861
Ensembl chr19:10,644,244...10,653,800
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:12053272 |
RGD:4891998 |
NCBI chr 8:128,740,756...128,754,514
Ensembl chr 8:128,740,756...128,754,514
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
IEP |
mRNA,protein:increased expression:cerebellum, hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
IEP |
protein:increased expression:cerebellum,hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr 2:148,722,343...148,755,781
Ensembl chr 2:148,722,231...148,755,520
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
|
IEP |
|
RGD |
PMID:18538309 |
RGD:7364785 |
NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
|
|
G |
Gjb6 |
gap junction protein, beta 6 |
|
IEP |
|
RGD |
PMID:18538309 |
RGD:7364785 |
NCBI chr15:37,400,888...37,411,656
Ensembl chr15:37,400,889...37,410,848
|
|
G |
Il16 |
interleukin 16 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:14698845 |
RGD:1354526 |
NCBI chr 1:145,781,923...145,881,538
Ensembl chr 1:145,781,928...145,870,912
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
IEP |
protein:increased expression:astrocyte |
RGD |
PMID:11870869 |
RGD:1642006 |
NCBI chr20:13,715,219...13,732,980
Ensembl chr20:13,732,198...13,732,859
|
|
G |
Mt3 |
metallothionein 3 |
|
IEP |
|
RGD |
PMID:16612977 |
RGD:2289373 |
NCBI chr19:11,324,708...11,326,112
Ensembl chr19:11,324,698...11,326,139
|
|
G |
Parg |
poly (ADP-ribose) glycohydrolase |
|
IEP |
mRNA:decreased expression:hippocampus |
RGD |
PMID:18057239 |
RGD:2316738 |
NCBI chr16:8,350,168...8,457,999
Ensembl chr16:8,350,326...8,457,996
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
IEP |
mRNA,protein:increased expression,increased activity:neuron, glial cell: |
RGD |
PMID:18057239 |
RGD:2316738 |
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
S100b |
S100 calcium binding protein B |
|
IEP |
protein:decreased expression:cerebellum, cerebral cortex |
RGD |
PMID:17376896 |
RGD:5508841 |
NCBI chr20:13,130,633...13,142,856
Ensembl chr20:13,130,636...13,142,856
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
IEP |
protein:increased expression:brain (rat) |
RGD |
PMID:12106671 |
RGD:38549588 |
NCBI chr10:63,153,656...63,188,377
Ensembl chr10:63,153,651...63,176,463
|
|
G |
Xbp1 |
X-box binding protein 1 |
|
IEP |
mRNA,protein:altered expression:cerebellum,hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chr14:85,753,736...85,758,820
Ensembl chr14:85,753,760...85,758,145
|
|
|
G |
Il23a |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:16923792 |
RGD:39457937 |
NCBI chr 7:2,710,609...2,712,723
Ensembl chr 7:2,710,609...2,712,723
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17387165 |
|
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
|
G |
C3 |
complement C3 |
treatment |
ISO |
|
RGD |
PMID:16947020 |
RGD:7401280 |
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
Coq7 |
coenzyme Q7, hydroxylase |
susceptibility |
ISO |
|
RGD |
PMID:23166727 |
RGD:10402105 |
NCBI chr 1:188,176,060...188,190,874
Ensembl chr 1:188,174,874...188,190,860
|
|
G |
Il18 |
interleukin 18 |
treatment |
ISO |
|
RGD |
PMID:16767432 |
RGD:8655941 |
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il2 |
interleukin 2 |
treatment |
ISO |
|
RGD |
PMID:9399664 |
RGD:8663451 |
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
ISO |
|
RGD |
PMID:21278795 |
RGD:36049796 |
NCBI chr 7:64,922,830...64,982,224
Ensembl chr 7:64,923,615...64,982,281
|
|
G |
Jam3 |
junctional adhesion molecule 3 |
|
ISO |
|
RGD |
PMID:15994945 |
RGD:7488936 |
NCBI chr 8:28,147,110...28,208,466
Ensembl chr 8:28,147,111...28,208,466
|
|
G |
Lect2 |
leukocyte cell-derived chemotaxin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30453282 |
|
NCBI chr17:8,489,261...8,495,483
Ensembl chr17:8,489,266...8,495,496
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16565519 |
|
NCBI chr 7:26,946,124...26,984,400
Ensembl chr 7:26,946,125...26,984,400
|
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment severity |
ISO IDA |
mRNA:increased expression:retina (mouse) human gene in mouse model |
RGD |
PMID:12766088, PMID:26610445, PMID:11292663, PMID:12766088 |
RGD:8547735, RGD:11073722, RGD:8547737, RGD:8547735 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Smo |
smoothened, frizzled class receptor |
treatment |
IMP |
|
RGD |
PMID:21063852 |
RGD:12859045 |
NCBI chr 4:57,019,941...57,041,779
Ensembl chr 4:57,019,941...57,042,770
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:spinal cord (rat) |
RGD |
PMID:12098510 |
RGD:8655962 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Nefh |
neurofilament heavy |
|
ISO |
protein:decreased expression:spinal cord: |
RGD |
PMID:12742652 |
RGD:27226817 |
NCBI chr14:85,181,572...85,191,557
Ensembl chr14:85,181,572...85,191,557
|
|
G |
Plp1 |
proteolipid protein 1 |
|
ISO |
human sequence peptide in a mouse model; associated with Herpesviridae infections |
RGD |
PMID:12811845 |
RGD:30296670 |
NCBI chr X:107,494,326...107,511,355
Ensembl chr X:107,496,072...107,511,348
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
|
RGD |
PMID:17983428 |
RGD:13208507 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
|
G |
Mbl2 |
mannose binding lectin 2 |
susceptibility |
ISO |
DNA:polymorphisms, haplotype:promoter,exon: |
RGD |
PMID:19827946 |
RGD:12910843 |
NCBI chr 1:248,435,069...248,442,669
Ensembl chr 1:248,723,397...248,729,962
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
RNA:increased expression:ileum |
RGD |
PMID:25838265 |
RGD:40925950 |
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
|
|
|
G |
Commd1 |
copper metabolism domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17919502 |
|
NCBI chr14:107,664,321...107,759,974
Ensembl chr14:107,664,255...107,760,191
|
|
G |
Dnm1 |
dynamin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18806795 |
|
NCBI chr 3:11,338,081...11,382,043
Ensembl chr 3:11,338,083...11,382,043
|
|
|
G |
Cd40 |
CD40 molecule |
treatment |
IDA |
|
RGD |
PMID:19269163 |
RGD:11352683 |
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
IDA |
|
RGD |
PMID:19269163 |
RGD:11352683 |
NCBI chr X:159,703,703...159,714,886
Ensembl chr X:159,703,578...159,716,562
|
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
ISO |
|
RGD |
PMID:23526225 |
RGD:13831300 |
NCBI chr 9:84,569,601...84,593,565
Ensembl chr 9:84,569,597...84,593,565
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Cd86 |
CD86 molecule |
treatment |
ISO |
|
RGD |
PMID:25344652 |
RGD:11354965 |
NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
IEP |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Faslg |
Fas ligand |
treatment |
IEP |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Il23a |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:19935773, PMID:26344076 |
RGD:5037240, RGD:11251537 |
NCBI chr 7:2,710,609...2,712,723
Ensembl chr 7:2,710,609...2,712,723
|
|
|
G |
A2m |
alpha-2-macroglobulin |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:6163339 |
RGD:10046032 |
NCBI chr 4:154,309,426...154,359,138
Ensembl chr 4:154,309,426...154,359,137
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
IEP ISO |
mRNA:altered expression:liver CTD Direct Evidence: marker/mechanism mRNA:decreased expression:intestinal mucosa (rat) |
CTD |
PMID:17827786, PMID:19152228, PMID:17827786 |
RGD:2315573, RGD:11040994 |
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
|
IEP |
mRNA:decreased expression:kidney |
RGD |
PMID:22974786 |
RGD:11038789 |
NCBI chr 1:101,954,786...102,013,252
Ensembl chr 1:101,959,540...102,013,243
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
|
IEP |
mRNA:decreased expression:small intestine |
RGD |
PMID:19152228 |
RGD:2315573 |
NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
|
|
G |
Acan |
aggrecan |
treatment |
IEP |
|
RGD |
PMID:25821409 |
RGD:12879456 |
NCBI chr 1:140,762,758...140,824,441
Ensembl chr 1:140,762,758...140,824,441
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IEP |
|
RGD |
PMID:20213806 |
RGD:2325221 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988084 |
|
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988084 |
|
NCBI chr X:113,596,247...113,660,024
Ensembl chr X:113,596,239...113,659,944
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988084 |
|
NCBI chr 1:276,240,703...276,290,012
Ensembl chr 1:276,240,703...276,290,008
|
|
G |
Adam10 |
ADAM metallopeptidase domain 10 |
|
IEP |
|
RGD |
PMID:23897050 |
RGD:13703039 |
NCBI chr 8:77,107,355...77,237,483
Ensembl chr 8:77,107,536...77,237,483
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
IEP |
|
RGD |
PMID:23897050 |
RGD:13703039 |
NCBI chr 6:43,400,525...43,448,280
Ensembl chr 6:43,400,528...43,448,280
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
IEP ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326410, PMID:21681567, PMID:19026984 |
RGD:5685385, RGD:5686814 |
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adk |
adenosine kinase |
|
IMP |
|
RGD |
PMID:11160636 |
RGD:6482663 |
NCBI chr15:3,033,535...3,435,888
Ensembl chr15:3,033,495...3,435,888
|
|
G |
Ahcy |
adenosylhomocysteinase |
|
IDA |
|
RGD |
PMID:11123369 |
RGD:1598898 |
NCBI chr 3:150,587,833...150,603,057
Ensembl chr 3:150,587,833...150,603,082
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25194622 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
treatment |
IDA |
|
RGD |
PMID:22391142 |
RGD:10041007 |
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20472598 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:19675173 |
RGD:5509599 |
NCBI chr10:56,953,692...56,962,145
Ensembl chr10:56,953,691...56,962,161
|
|
G |
Anxa1 |
annexin A1 |
|
IMP ISO |
|
RGD |
PMID:10403283, PMID:23267026 |
RGD:2306928, RGD:7421573 |
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
|
IMP |
|
RGD |
PMID:16947396 |
RGD:2313925 |
NCBI chr10:89,251,370...89,259,313
Ensembl chr10:89,251,370...89,259,313
|
|
G |
Apoa4 |
apolipoprotein A4 |
|
IEP |
protein:decreased expression:blood serum (rat) |
RGD |
PMID:10892728 |
RGD:5685694 |
NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376
|
|
G |
Arrb1 |
arrestin, beta 1 |
|
IEP |
protein:increased expression:knee, synoviocyte (rat) |
RGD |
PMID:20965243 |
RGD:5509895 |
NCBI chr 1:164,502,099...164,573,947
Ensembl chr 1:164,502,389...164,593,139
|
|
G |
Arrb2 |
arrestin, beta 2 |
|
IEP |
protein:increased expression:knee, synoviocyte (rat) |
RGD |
PMID:20965243 |
RGD:5509895 |
NCBI chr10:57,040,252...57,048,045
Ensembl chr10:57,040,267...57,048,134
|
|
G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
|
IMP |
|
RGD |
PMID:17408934 |
RGD:5144054 |
NCBI chr 9:78,862,013...78,882,061
Ensembl chr 9:78,862,013...78,882,060
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:21199477, PMID:22978269 |
RGD:10054249, RGD:10054498 |
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:21199477, PMID:22978269 |
RGD:10054249, RGD:10054498 |
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
|
IMP |
|
RGD |
PMID:15001555 |
RGD:1625760 |
NCBI chr 6:129,437,423...129,441,553
Ensembl chr 6:129,438,158...129,440,574
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:21406003 |
RGD:6483549 |
NCBI chr 2:187,741,770...187,748,445
Ensembl chr 2:187,741,770...187,742,747
|
|
G |
Btk |
Bruton tyrosine kinase |
treatment |
IMP |
|
RGD |
PMID:22228807 |
RGD:11040701 |
NCBI chr X:105,360,922...105,390,580
Ensembl chr X:105,360,922...105,390,580
|
|
G |
C3 |
complement C3 |
treatment |
ISO IDA |
|
RGD |
PMID:20051658, PMID:7347767 |
RGD:7411688, RGD:11041098 |
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
C5 |
complement C5 |
|
ISO IMP |
|
RGD |
PMID:20975959, PMID:12355496 |
RGD:5130175, RGD:1600637 |
NCBI chr 3:14,049,993...14,113,931 NCBI chr 3:14,206,466...14,229,141
Ensembl chr 3:14,049,995...14,229,080
|
|
G |
Cabin1 |
calcineurin binding protein 1 |
|
ISO |
|
RGD |
PMID:22275266 |
RGD:10054391 |
NCBI chr20:13,836,032...13,963,003
Ensembl chr20:13,836,030...13,963,003
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16690336 |
|
NCBI chr 1:184,184,018...184,188,922
Ensembl chr 1:184,184,020...184,188,911
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22450443 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cbl |
Cbl proto-oncogene |
treatment |
IDA |
|
RGD |
PMID:16984225 |
RGD:2306289 |
NCBI chr 8:48,481,256...48,564,775
Ensembl chr 8:48,489,036...48,564,722
|
|
G |
Cblb |
Cbl proto-oncogene B |
|
IMP |
|
RGD |
PMID:16984225 |
RGD:2306289 |
NCBI chr11:51,037,383...51,202,761
Ensembl chr11:51,037,393...51,202,820
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
IMP IDA IEP |
mRNA, protein:increased expression:synovium |
RGD |
PMID:18292571, PMID:24583103, PMID:17052673, PMID:18726678 |
RGD:2307052, RGD:11526142, RGD:2307143, RGD:2307008 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
IEP |
mRNA, protein:increased expression:synovium, monocytes |
RGD |
PMID:17052673 |
RGD:2307143 |
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
IMP IEP |
mRNA, protein:increased expression:synovium, monocytes |
RGD |
PMID:9637726, PMID:17052673 |
RGD:4889940, RGD:2307143 |
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
onset |
ISO |
|
RGD |
PMID:17178563 |
RGD:6483780 |
NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
ISO IEP |
|
RGD |
PMID:18608173, PMID:14674010 |
RGD:5688144, RGD:1582346 |
NCBI chr 8:132,996,646...133,002,201
Ensembl chr 8:132,996,649...133,002,201
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
IEP |
|
RGD |
PMID:16320322 |
RGD:4144893 |
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
treatment |
IEP |
mRNA:increased expression:ankle (rat) |
RGD |
PMID:14674010, PMID:22289897 |
RGD:1582346, RGD:5687744 |
NCBI chr 8:133,192,398...133,215,599
Ensembl chr 8:133,197,032...133,215,614
|
|
G |
Cd28 |
Cd28 molecule |
|
IEP |
|
RGD |
PMID:18601859 |
RGD:2307202 |
NCBI chr 9:67,546,408...67,573,858
Ensembl chr 9:67,546,408...67,571,871
|
|
G |
Cd4 |
Cd4 molecule |
treatment |
ISO IMP |
|
RGD |
PMID:15479897, PMID:12010568 |
RGD:10058957, RGD:10058960 |
NCBI chr 4:157,381,862...157,408,357
Ensembl chr 4:157,383,052...157,408,176
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20435931 |
RGD:5490544 |
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
IDA ISO IEP |
protein:increased expression:plasma (rat) |
RGD |
PMID:27218142, PMID:7689748, PMID:22611405 |
RGD:11344958, RGD:11352696, RGD:11352298 |
NCBI chr X:159,703,703...159,714,886
Ensembl chr X:159,703,578...159,716,562
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
|
IEP |
protein:increased expression:joint, macrophage, lymphocyte |
RGD |
PMID:8639178 |
RGD:2289388 |
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cd46 |
CD46 molecule |
|
ISO |
|
RGD |
PMID:21852528 |
RGD:6483461 |
NCBI chr13:113,786,525...113,818,741
Ensembl chr13:113,787,349...113,817,995
|
|
G |
Cd59 |
CD59 molecule |
|
IDA |
|
RGD |
PMID:14519760 |
RGD:1600483 |
NCBI chr 3:94,010,481...94,028,660
Ensembl chr 3:94,010,475...94,028,621
|
|
G |
Cd69 |
Cd69 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12882836 |
|
NCBI chr 4:163,041,147...163,049,065
Ensembl chr 4:163,041,141...163,049,084
|
|
G |
Cd80 |
Cd80 molecule |
|
ISO |
|
RGD |
PMID:22004797 |
RGD:6902903 |
NCBI chr11:64,815,201...64,855,293
Ensembl chr11:64,827,635...64,855,353
|
|
G |
Cdc42 |
cell division cycle 42 |
|
ISO |
protein:increased activation:bone marrow, macrophage |
RGD |
PMID:21266780 |
RGD:5688271 |
NCBI chr 5:155,690,267...155,728,385
Ensembl chr 5:155,691,390...155,728,300
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
treatment |
ISO |
|
RGD |
PMID:10395320 |
RGD:8552686 |
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
|
|
G |
Cfh |
complement factor H |
|
ISO |
|
RGD |
PMID:19828624 |
RGD:5684557 |
NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16200597 PMID:21188452 PMID:23326410 PMID:24709313 PMID:25194622 PMID:25481498 PMID:26070417 PMID:29908986 PMID:29935983 |
|
NCBI chr 7:139,454,945...139,484,403
Ensembl chr 7:139,455,242...139,483,997
|
|
G |
Cp |
ceruloplasmin |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19330884, PMID:19205849 |
RGD:2314686 |
NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
|
|
G |
Cpox |
coproporphyrinogen oxidase |
|
IEP |
protein:decreased activity:liver (rat) |
RGD |
PMID:9173682 |
RGD:1600958 |
NCBI chr11:44,039,665...44,049,648
Ensembl chr11:44,039,669...44,049,648
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
IMP |
|
RGD |
PMID:17550594 |
RGD:1626231 |
NCBI chr10:92,191,473...92,233,662
Ensembl chr10:92,191,718...92,232,645
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19330884 |
|
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
|
RGD |
PMID:12742377 |
RGD:11039465 |
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
Csk |
C-terminal Src kinase |
|
IMP |
|
RGD |
PMID:10411542 |
RGD:5134371 |
NCBI chr 8:62,405,714...62,424,707
Ensembl chr 8:62,405,715...62,424,303
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
treatment |
IMP ISO |
|
RGD |
PMID:22354915, PMID:7543497 |
RGD:7204500, RGD:7204519 |
NCBI chr 9:67,699,397...67,706,068
Ensembl chr 9:67,699,379...67,706,065
|
|
G |
Ctsb |
cathepsin B |
|
IEP |
mRNA:increased expression:knee joint, synovium (rat) |
RGD |
PMID:17195213 |
RGD:2315521 |
NCBI chr15:46,316,741...46,337,613
Ensembl chr15:46,316,741...46,337,612
|
|
G |
Ctsk |
cathepsin K |
|
IEP |
mRNA:increased expression:synovium, bone marrow |
RGD |
PMID:15353610 |
RGD:1601025 |
NCBI chr 2:196,655,469...196,666,447
Ensembl chr 2:196,655,469...196,666,446
|
|
G |
Ctss |
cathepsin S |
|
ISO |
|
RGD |
PMID:21439785 |
RGD:5686915 |
NCBI chr 2:197,655,780...197,679,768
Ensembl chr 2:197,655,786...197,679,458
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:11465708 |
RGD:4892002 |
NCBI chr19:10,644,267...10,654,861
Ensembl chr19:10,644,244...10,653,800
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:17123734, PMID:11465708 |
RGD:4891969, RGD:4892002 |
NCBI chr 8:128,740,756...128,754,514
Ensembl chr 8:128,740,756...128,754,514
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:19096963 |
RGD:4889415 |
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
severity |
IMP |
|
RGD |
PMID:10358204 |
RGD:5135272 |
NCBI chr14:18,860,201...18,920,839
Ensembl chr14:18,860,264...18,862,407
|
|
G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
IMP |
|
RGD |
PMID:15182735 |
RGD:2316231 |
NCBI chr19:42,066,103...42,087,906
Ensembl chr19:42,066,351...42,082,012
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25194984 |
|
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
|
|
G |
Drd1 |
dopamine receptor D1 |
treatment |
IEP IDA |
mRNA:increased expression:corpus striatum (rat) |
RGD |
PMID:23762129, PMID:23762129 |
RGD:7248592, RGD:7248592 |
NCBI chr17:11,099,736...11,104,352
Ensembl chr17:11,101,306...11,103,541
|
|
G |
Drd2 |
dopamine receptor D2 |
treatment |
IEP IDA |
mRNA:increased expression:corpus striatum (rat) |
RGD |
PMID:23762129, PMID:23762129 |
RGD:7248592, RGD:7248592 |
NCBI chr 8:53,678,777...53,743,643
Ensembl chr 8:53,678,777...53,743,642
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
mRNA:increased expression:inguinal lymph node (mouse) |
RGD |
PMID:22249931 |
RGD:8661695 |
NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7589090 |
|
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Esr1 |
estrogen receptor 1 |
treatment |
ISO |
associated with Osteoporosis |
RGD |
PMID:20112355 |
RGD:10045851 |
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Esr2 |
estrogen receptor 2 |
|
IDA |
|
RGD |
PMID:16269464 |
RGD:5508854 |
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
F2 |
coagulation factor II |
|
ISO |
|
RGD |
PMID:21436072 |
RGD:5147764 |
NCBI chr 3:80,529,468...80,542,993
Ensembl chr 3:80,529,428...80,543,031
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
severity |
ISO |
|
RGD |
PMID:19674841 |
RGD:7387269 |
NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
|
ISO |
|
RGD |
PMID:12511586 |
RGD:735010 |
NCBI chr 2:25,222,324...25,235,275
Ensembl chr 2:25,222,328...25,235,275
|
|
G |
Faslg |
Fas ligand |
treatment |
IMP |
|
RGD |
PMID:22354915 |
RGD:7204500 |
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Fcgr1a |
Fc fragment of IgG receptor Ia |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12875993, PMID:16670289 |
RGD:9685708 |
NCBI chr 2:198,430,536...198,439,453
Ensembl chr 2:198,430,530...198,458,041
|
|
G |
Fcgr2a |
Fc fragment of IgG receptor IIa |
onset |
ISO |
|
RGD |
PMID:18354234, PMID:16623928 |
RGD:5508446, RGD:5508457 |
NCBI chr13:91,146,878...91,163,691
Ensembl chr13:91,168,973...91,198,036 Ensembl chr13:91,168,973...91,198,036
|
|
G |
Fcgr2b |
Fc fragment of IgG receptor IIb |
|
ISO |
|
RGD |
PMID:23341540 |
RGD:11344930 |
NCBI chr13:89,329,298...89,343,916
Ensembl chr13:89,327,794...89,433,815
|
|
G |
Fgf8 |
fibroblast growth factor 8 |
|
IMP |
|
RGD |
PMID:18699993 |
RGD:2314157 |
NCBI chr 1:265,492,949...265,498,965
Ensembl chr 1:265,493,124...265,498,831
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
ISO |
|
RGD |
PMID:22833219 |
RGD:10402072 |
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
ISO |
|
RGD |
PMID:19180491 |
RGD:6483591 |
NCBI chr12:9,033,993...9,205,886
Ensembl chr12:9,034,308...9,205,905
|
|
G |
Flt3 |
Fms related receptor tyrosine kinase 3 |
|
IAGP |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr12:9,360,439...9,437,004
Ensembl chr12:9,360,672...9,436,570
|
|
G |
Foxp3 |
forkhead box P3 |
treatment |
IEP |
mRNA,protein:decreased expression:lung |
RGD |
PMID:29264841, PMID:23643080 |
RGD:38549364, RGD:38599003 |
NCBI chr X:15,753,175...15,768,648
Ensembl chr X:15,753,175...15,768,522
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
|
IMP |
|
RGD |
PMID:23165424 |
RGD:7207259 |
NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
|
|
G |
Gli1 |
GLI family zinc finger 1 |
treatment |
IEP |
|
RGD |
PMID:25821409 |
RGD:12879456 |
NCBI chr 7:70,620,794...70,633,171
Ensembl chr 7:70,620,766...70,630,338
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
|
ISO |
|
RGD |
PMID:23911657 |
RGD:11051957 |
NCBI chr 1:90,063,411...90,091,287
Ensembl chr 1:90,063,411...90,091,287
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
disease_progression treatment |
IEP |
protein:increased expression:aorta (rat) protein:altered expression:T cell (rat) |
RGD |
PMID:28653218, PMID:28349925, PMID:28631356 |
RGD:13513975, RGD:13513979, RGD:13513976 |
NCBI chr 1:219,536,220...219,544,329
Ensembl chr 1:219,536,220...219,544,328
|
|
G |
Grn |
granulin precursor |
|
ISO |
|
RGD |
PMID:21393509 |
RGD:5509782 |
NCBI chr10:90,377,103...90,383,207
Ensembl chr10:90,376,933...90,383,205
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16713974 |
|
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
|
|
G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
|
IEP |
mRNA,protein:altered expression:bone: |
RGD |
PMID:25264706 |
RGD:9686117 |
NCBI chr10:31,561,838...31,590,624
Ensembl chr10:31,561,895...31,588,943
|
|
G |
Hdac6 |
histone deacetylase 6 |
treatment |
ISO |
|
RGD |
PMID:23541634 |
RGD:9681550 |
NCBI chr X:15,295,372...15,316,673
Ensembl chr X:15,295,473...15,316,671
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
IDA |
|
RGD |
PMID:21679445 |
RGD:8693318 |
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
IEP |
protein:altered localization:cytoplasm, extracellular matrix |
RGD |
PMID:12384917 |
RGD:728698 |
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
|
RGD |
PMID:17119970 |
RGD:5508468 |
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
|
|
G |
Hp |
haptoglobin |
|
IEP |
mRNA, protein:increased expression:tendon, ankle protein:increased expression:serum |
RGD |
PMID:12801280, PMID:15899029 |
RGD:1626375, RGD:1626370 |
NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
|
IDA |
|
RGD |
PMID:15529360, PMID:10882416 |
RGD:1624244, RGD:12910542 |
NCBI chr 9:61,680,529...61,691,202
Ensembl chr 9:61,680,530...61,690,956
|
|
G |
Ifng |
interferon gamma |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19203382 PMID:22450443, PMID:12412757, PMID:7774621 |
RGD:2311498, RGD:10755750 |
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
IEP |
protein:decreased expression:plasma |
RGD |
PMID:19246225 |
RGD:2306697 |
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
IEP |
mRNA, protein:increased expression:kidney, serum |
RGD |
PMID:14642797 |
RGD:10402760 |
NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
treatment |
ISO IMP |
|
RGD |
PMID:21087862, PMID:19652024 |
RGD:7495772, RGD:7495778 |
NCBI chr16:74,177,233...74,230,809
Ensembl chr16:74,177,215...74,230,815
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
treatment |
IDA |
|
RGD |
PMID:16684367 |
RGD:12791276 |
NCBI chr X:156,254,187...156,280,046
Ensembl chr X:156,257,173...156,270,748
|
|
G |
Il10 |
interleukin 10 |
treatment |
IEP ISO IDA |
CTD Direct Evidence: marker/mechanism|therapeutic protein:decreased expression:serum: |
CTD |
PMID:20974942 PMID:22450443, PMID:19193354, PMID:19169271, PMID:23140046, PMID:22052031, PMID:15270736 |
RGD:2311059, RGD:8662976, RGD:7193038, RGD:7364838, RGD:1626677 |
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il13 |
interleukin 13 |
treatment |
ISO IMP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10444273, PMID:17665443, PMID:11860705 |
RGD:4889497, RGD:8549606 |
NCBI chr10:38,982,909...38,985,466
Ensembl chr10:38,982,909...38,985,466
|
|
G |
Il15 |
interleukin 15 |
|
ISO |
|
RGD |
PMID:20188418 |
RGD:5000761 |
NCBI chr19:23,542,606...23,624,366
Ensembl chr19:23,542,889...23,554,594
|
|
G |
Il17a |
interleukin 17A |
treatment |
IMP ISO IEP IDA |
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat) |
CTD |
PMID:20974942, PMID:20925596, PMID:23377547, PMID:21194185, PMID:20925596 |
RGD:4781444, RGD:9130803, RGD:9068936, RGD:4781444 |
NCBI chr 9:26,841,299...26,844,786
Ensembl chr 9:26,841,299...26,844,786
|
|
G |
Il18 |
interleukin 18 |
disease_progression |
IEP IMP |
|
RGD |
PMID:19096963, PMID:15147345 |
RGD:4889415, RGD:4889503 |
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il1a |
interleukin 1 alpha |
|
IDA IEP |
protein:increased expression:serum: |
RGD |
PMID:20379758, PMID:19169271 |
RGD:6907373, RGD:8662976 |
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
IDA IEP ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat) |
CTD |
PMID:19330884 PMID:20131233 PMID:20974942 PMID:22450443, PMID:21557995, PMID:29408684, PMID:24028507, PMID:23140046 |
RGD:7175317, RGD:13792834, RGD:10755447, RGD:7193038 |
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20472598 |
|
NCBI chr 9:47,133,483...47,184,316
Ensembl chr 9:47,134,034...47,182,170
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO IEP |
rat model treated with human protein human gene in a rat model mRNA:increased expression:popliteal lymph node (rat) mouse model treated with human protein |
RGD |
PMID:15270736, PMID:12727108, PMID:10921508, PMID:22267332, PMID:23006786 |
RGD:1626677, RGD:8551745, RGD:8551741, RGD:8549801, RGD:6907376 |
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
|
|
G |
Il2 |
interleukin 2 |
treatment |
IEP IDA |
protein:increased expression:serum: |
RGD |
PMID:19169271, PMID:2492102 |
RGD:8662976, RGD:10047055 |
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
|
|
G |
Il20 |
interleukin 20 |
|
IMP |
|
RGD |
PMID:20722035 |
RGD:5147393 |
NCBI chr13:47,644,071...47,651,487
Ensembl chr13:47,644,071...47,647,715
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
IDA |
|
RGD |
PMID:17928458 |
RGD:2325988 |
NCBI chr17:70,500,672...70,547,929
Ensembl chr17:70,499,083...70,548,071
|
|
G |
Il33 |
interleukin 33 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20472598 |
|
NCBI chr 1:248,112,611...248,147,030
Ensembl chr 1:248,132,090...248,147,029
|
|
G |
Il4 |
interleukin 4 |
treatment |
IMP ISO IEP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10444273, PMID:16869003, PMID:23972727, PMID:23140046 |
RGD:2317300, RGD:10402790, RGD:7193038 |
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Il6 |
interleukin 6 |
treatment |
IEP ISO IDA IMP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20131233 PMID:20974942 PMID:22450443, PMID:24028507, PMID:8607900, PMID:10381487, PMID:23503893 |
RGD:10755447, RGD:11060267, RGD:11049553, RGD:11049551 |
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
|
ISO |
|
RGD |
PMID:20626857 |
RGD:5509945 |
NCBI chr 2:44,279,199...44,319,427
Ensembl chr 2:44,289,393...44,314,944
|
|
G |
Itga4 |
integrin subunit alpha 4 |
treatment |
IMP |
|
RGD |
PMID:12969328 |
RGD:9698440 |
NCBI chr 3:66,178,745...66,265,547
Ensembl chr 3:66,193,059...66,263,960
|
|
G |
Itgb2 |
integrin subunit beta 2 |
|
IMP |
|
RGD |
PMID:8881759 |
RGD:6482229 |
NCBI chr20:11,777,773...11,815,647
Ensembl chr20:11,777,783...11,815,647
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
IMP |
protein:increased expression:endothelial cell |
RGD |
PMID:16869003 |
RGD:2317300 |
NCBI chr10:92,667,869...92,783,413
Ensembl chr10:92,667,869...92,783,410
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:19265135 |
RGD:6482234 |
NCBI chr 3:130,079,361...130,114,781
Ensembl chr 3:130,079,361...130,114,770
|
|
G |
Jak1 |
Janus kinase 1 |
treatment |
IMP |
|
RGD |
PMID:29452839 |
RGD:19165139 |
NCBI chr 5:119,982,503...120,091,452
Ensembl chr 5:119,982,943...120,083,904
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO IDA |
|
RGD |
PMID:22339472, PMID:23711144, PMID:22800927 |
RGD:10403066, RGD:10403081, RGD:10403074 |
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
|
|
G |
Jak3 |
Janus kinase 3 |
treatment |
IMP IEP |
|
RGD |
PMID:25762693, PMID:18234077, PMID:21434883 |
RGD:11533938, RGD:11533944, RGD:11533942 |
NCBI chr16:20,107,471...20,120,678
Ensembl chr16:20,109,200...20,120,668
|
|
G |
Klkb1 |
kallikrein B1 |
|
IMP IEP |
|
RGD |
PMID:22739815, PMID:9783057 |
RGD:7297047, RGD:7327138 |
NCBI chr16:50,151,127...50,175,407
Ensembl chr16:50,152,008...50,175,458
|
|
G |
Kng2 |
kininogen 2 |
|
IEP |
peptidoglycan-polysaccharide-induced arthritis in Lewis rats |
RGD |
PMID:9214434, PMID:1996642 |
RGD:1600547, RGD:11059895 |
NCBI chr11:81,509,185...81,516,759
|
|
G |
Kyat1 |
kynurenine aminotransferase 1 |
|
IMP |
|
RGD |
PMID:16984225 |
RGD:2306289 |
NCBI chr 3:8,752,289...8,785,617
Ensembl chr 3:8,752,625...8,766,433
|
|
G |
Lep |
leptin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15142272 |
|
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Lgals3 |
galectin 3 |
|
IEP |
|
RGD |
PMID:16507131 |
RGD:1625684 |
NCBI chr15:24,153,602...24,165,537
Ensembl chr15:24,141,651...24,165,537
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
ISO |
|
RGD |
PMID:16331767 |
RGD:10412332 |
NCBI chr 1:15,412,603...15,613,752
Ensembl chr 1:15,412,603...15,613,746
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
IDA |
|
RGD |
PMID:10765927 |
RGD:1642012 |
NCBI chr20:13,715,219...13,732,980
Ensembl chr20:13,732,198...13,732,859
|
|
G |
Mir152 |
microRNA 152 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism miRNA:decreased exression:synovial membrane of synovial joint |
CTD |
PMID:25194984, PMID:25194984 |
RGD:21066343 |
NCBI chr10:84,719,319...84,719,403
Ensembl chr10:84,719,319...84,719,403
|
|
G |
Mir26a |
microRNA 26a |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24423102 |
|
NCBI chr 8:127,714,441...127,714,530
Ensembl chr 8:127,714,441...127,714,530
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
|
IDA IEP |
|
RGD |
PMID:21288455, PMID:24011916, PMID:21108488 |
RGD:7207362, RGD:8549748, RGD:7207365 |
NCBI chr 8:5,703,206...5,723,593
Ensembl chr 8:5,703,206...5,723,591
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
treatment |
IEP IDA |
|
RGD |
PMID:24244039, PMID:11435459 |
RGD:8694124, RGD:1582329 |
NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:ankle joint |
CTD |
PMID:20974942, PMID:20703013, PMID:24244039, PMID:24244039, PMID:24011916, PMID:21679445 |
RGD:7241231, RGD:8694124, RGD:8694124, RGD:8549748, RGD:8693318 |
NCBI chr 8:5,676,608...5,698,579
Ensembl chr 8:5,676,665...5,698,579
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
protein:increased expression:cartilage, serum, synovial fluid |
RGD |
PMID:17463159 |
RGD:1642035 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22450443 |
|
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
|
|
G |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
susceptibility |
ISO |
DNA:transversion: :m.7778G>T (mouse) |
RGD |
PMID:19759059 |
RGD:5490297 |
NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
IEP |
|
RGD |
PMID:22391142 |
RGD:10041007 |
NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
|
ISO |
|
RGD |
PMID:20131263 |
RGD:8552884 |
NCBI chr 8:128,022,512...128,027,462
Ensembl chr 8:128,022,473...128,026,841
|
|
G |
Myod1 |
myogenic differentiation 1 |
treatment |
IEP |
|
RGD |
PMID:23781298 |
RGD:9686078 |
NCBI chr 1:102,396,538...102,399,248
Ensembl chr 1:102,396,538...102,399,248
|
|
G |
Myog |
myogenin |
treatment |
IDA |
|
RGD |
PMID:23781298 |
RGD:9686078 |
NCBI chr13:51,126,459...51,129,048
Ensembl chr13:51,126,459...51,129,048
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
severity |
IAGP |
DNA:missense mutations:cds:p.M106V, p.M153T (rat) |
RGD |
PMID:12461526 |
RGD:628543 |
NCBI chr12:25,497,104...25,506,300
Ensembl chr12:25,497,104...25,506,300
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:21424514, PMID:20131263 |
RGD:5508728, RGD:8552884 |
NCBI chr19:19,342,061...19,389,366
Ensembl chr19:19,332,594...19,377,492
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
IMP ISO |
protein:increased expression:ankle joint (mouse) |
RGD |
PMID:12826065, PMID:21880869 |
RGD:1358527, RGD:5509060 |
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IEP |
|
RGD |
PMID:29337196 |
RGD:13504725 |
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Npsr1 |
neuropeptide S receptor 1 |
treatment |
IMP |
|
RGD |
PMID:24884567 |
RGD:9831205 |
NCBI chr 8:25,246,174...25,483,582
Ensembl chr 8:25,246,292...25,482,647
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
severity |
ISO |
|
RGD |
PMID:16905546 |
RGD:11073695 |
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
ISO |
|
RGD |
PMID:21859686 |
RGD:6480864 |
NCBI chr 1:100,554,577...100,559,896
Ensembl chr 1:100,554,544...100,559,942
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
ISO |
|
RGD |
PMID:21859686 |
RGD:6480864 |
NCBI chr 3:80,004,130...80,014,197
Ensembl chr 3:80,004,130...80,012,750
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
IEP |
|
RGD |
PMID:18706093 |
RGD:2300006 |
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
|
|
G |
Nts |
neurotensin |
|
IEP |
|
RGD |
PMID:8518953 |
RGD:9743903 |
NCBI chr 7:44,111,594...44,120,998
Ensembl chr 7:44,111,151...44,121,130
|
|
G |
Orm1 |
orosomucoid 1 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:16166348 |
RGD:2316639 |
NCBI chr 5:79,179,668...79,182,820
Ensembl chr 5:79,179,417...79,182,820
|
|
G |
P2ry12 |
purinergic receptor P2Y12 |
|
IMP |
|
RGD |
PMID:22028806 |
RGD:6480518 |
NCBI chr 2:149,440,807...149,482,592
Ensembl chr 2:149,441,598...149,444,548
|
|
G |
Pam |
peptidylglycine alpha-amidating monooxygenase |
|
IDA |
|
RGD |
PMID:17138865 |
RGD:6483527 |
NCBI chr 9:111,028,543...111,177,588
Ensembl chr 9:111,028,575...111,177,602
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
severity |
ISO |
|
RGD |
PMID:16356201 |
RGD:5684009 |
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
severity |
ISO |
protein:increased expression:knee joint, blood vessels (mouse) |
RGD |
PMID:22548760, PMID:14613294, PMID:21982514 |
RGD:6484738, RGD:6771222, RGD:6771177 |
NCBI chr10:94,850,971...94,913,202
|
|
G |
Pgf |
placental growth factor |
|
ISO |
|
RGD |
PMID:19180491 |
RGD:6483591 |
NCBI chr 6:108,994,016...109,004,598
Ensembl chr 6:108,994,018...109,004,598
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
ISO |
|
RGD |
PMID:18412166 |
RGD:6482696 |
NCBI chr 5:166,602,053...166,628,028
Ensembl chr 5:166,602,053...166,628,028
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:20374644, PMID:18412166 |
RGD:6482684, RGD:6482696 |
NCBI chr 6:51,465,696...51,501,234
Ensembl chr 6:51,465,908...51,498,337
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
|
RGD |
PMID:20973954 |
RGD:6483801 |
NCBI chr15:3,644,296...3,650,765
Ensembl chr15:3,644,769...3,650,819
|
|
G |
Ptch1 |
patched 1 |
treatment |
IEP |
|
RGD |
PMID:25821409 |
RGD:12879456 |
NCBI chr17:1,032,242...1,085,885
Ensembl chr17:1,029,048...1,093,873
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
treatment disease_progression |
ISO IEP IMP |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:tarsal joint, synovium (rat) |
CTD |
PMID:18287210, PMID:20423341, PMID:11207665, PMID:18287210 |
RGD:10003041, RGD:10043377, RGD:10003052 |
NCBI chr 2:54,951,625...54,966,470
Ensembl chr 2:54,952,821...54,963,448
|
|
G |
Ptges |
prostaglandin E synthase |
|
IEP |
mRNA, protein:increased expression:paw |
RGD |
PMID:12707354 |
RGD:2300108 |
NCBI chr 3:9,727,408...9,738,752
Ensembl chr 3:9,727,408...9,738,752
|
|
G |
Ptges3 |
prostaglandin E synthase 3 |
|
IEP |
mRNA:increased expression:paw (rat) |
RGD |
PMID:12707354 |
RGD:2300108 |
NCBI chr 7:2,479,267...2,497,024
Ensembl chr 7:2,479,311...2,497,013
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
IEP |
mRNA, protein:increased expression:synovium |
RGD |
PMID:22289897 |
RGD:5687744 |
NCBI chr 3:15,560,685...15,582,339
Ensembl chr 3:15,560,712...15,582,344
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IMP IEP ISO |
mRNA, protein:increased expression:synovium protein:increased expression:autopod joint |
RGD |
PMID:18758904, PMID:22289897, PMID:21765105 |
RGD:2300221, RGD:5687744, RGD:5508310 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 |
|
IEP |
protein:increased expression:metatarsophalangeal joint, mononuclear cell (rat) |
RGD |
PMID:24998229 |
RGD:11532752 |
NCBI chr 2:206,342,066...206,390,348
Ensembl chr 2:206,342,066...206,390,348
|
|
G |
Rag2 |
recombination activating 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20974942 |
|
NCBI chr 3:91,191,837...91,200,134
Ensembl chr 3:91,191,837...91,200,134
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
ISO |
|
RGD |
PMID:21665435, PMID:19950279 |
RGD:5147558, RGD:5147586 |
NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
|
IEP |
|
RGD |
PMID:8343166 |
RGD:633930 |
NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
|
|
G |
S100a9 |
S100 calcium binding protein A9 |
|
IEP |
|
RGD |
PMID:8343166 |
RGD:633930 |
NCBI chr 2:190,097,436...190,100,209
Ensembl chr 2:190,097,554...190,100,276
|
|
G |
Serpinc1 |
serpin family C member 1 |
|
IEP |
protein:decreased expression:plasma |
RGD |
PMID:22781611 |
RGD:11035273 |
NCBI chr13:78,806,107...78,820,375
Ensembl chr13:78,805,347...78,833,192
|
|
G |
Sfrp4 |
secreted frizzled-related protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25194984 |
|
NCBI chr17:47,383,983...47,394,065
Ensembl chr17:47,297,489...47,394,328
|
|
G |
Shh |
sonic hedgehog signaling molecule |
treatment |
IEP |
|
RGD |
PMID:25821409 |
RGD:12879456 |
NCBI chr 4:718,538...727,691
Ensembl chr 4:718,538...727,691
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
severity |
ISO |
|
RGD |
PMID:17122779 |
RGD:5684943 |
NCBI chr 9:81,655,590...81,666,697
Ensembl chr 9:81,655,629...81,666,706
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
treatment |
IEP |
protein:decreased expression:articular cartilage of joint |
RGD |
PMID:10449524, PMID:9744360 |
RGD:634208, RGD:9999431 |
NCBI chr 3:160,799,979...160,802,228
Ensembl chr 3:160,799,981...160,802,433
|
|
G |
Smo |
smoothened, frizzled class receptor |
treatment |
IEP |
|
RGD |
PMID:25821409 |
RGD:12879456 |
NCBI chr 4:57,019,941...57,041,779
Ensembl chr 4:57,019,941...57,042,770
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
IEP |
mRNA:increased expression:mononuclear cell |
RGD |
PMID:16507131 |
RGD:1625684 |
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
|
|
G |
Spn |
sialophorin |
|
IMP |
associated with Staphylococcal Infections |
RGD |
PMID:7927732 |
RGD:2303983 |
NCBI chr 1:198,572,999...198,585,664
Ensembl chr 1:198,572,999...198,577,226
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
IDA ISO |
protein:increased tyrosine phosphorylation:macrophage, synovial cell CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15188379, PMID:14674010 |
RGD:1582346 |
NCBI chr 9:54,287,540...54,327,958
Ensembl chr 9:54,287,541...54,484,533
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
treatment |
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15188379 PMID:21937456, PMID:23711144 |
RGD:10403081 |
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Tac1 |
tachykinin, precursor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9259450 |
|
NCBI chr 4:33,638,853...33,646,819
Ensembl chr 4:33,638,709...33,646,819
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
IEP |
|
RGD |
PMID:29763498 |
RGD:15036801 |
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
IEP |
protein:increased expression:synovium |
RGD |
PMID:9010265 |
RGD:1601623 |
NCBI chr 8:124,310,288...124,399,345
Ensembl chr 8:124,312,754...124,399,494
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
|
RGD |
PMID:16879225 |
RGD:5685015 |
NCBI chr 3:142,748,673...142,752,325
Ensembl chr 3:142,748,674...142,752,325
|
|
G |
Timp4 |
TIMP metallopeptidase inhibitor 4 |
|
IMP |
|
RGD |
PMID:12483743 |
RGD:2290463 |
NCBI chr 4:147,156,948...147,163,467
Ensembl chr 4:147,156,948...147,163,467
|
|
G |
Tjp1 |
tight junction protein 1 |
|
IEP |
|
RGD |
PMID:18848892 |
RGD:2325138 |
NCBI chr 1:126,146,489...126,515,359
Ensembl chr 1:126,146,489...126,227,469
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
IEP ISO |
|
RGD |
PMID:21725847, PMID:20131263 |
RGD:7241099, RGD:8552884 |
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
|
|
G |
Tlr3 |
toll-like receptor 3 |
|
IEP IMP |
mRNA, protein:increased expression:spleen (rat) |
RGD |
PMID:20500834, PMID:20500834 |
RGD:5128706, RGD:5128706 |
NCBI chr16:50,016,466...50,031,011
Ensembl chr16:50,016,857...50,031,214
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
IDA IEP ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:serum: |
CTD |
PMID:7589090 PMID:9598899 PMID:19203382 PMID:19330884 PMID:19765281 PMID:20131233 PMID:20974942 PMID:21452922 PMID:22450443, PMID:23052485, PMID:29408684, PMID:24028507, PMID:24394943, PMID:19169271, PMID:21690068, PMID:23140046 |
RGD:7245941, RGD:13792834, RGD:10755447, RGD:10450611, RGD:8662976, RGD:8661761, RGD:7193038 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
|
IEP ISO |
mRNA:decreased expression:bone CTD Direct Evidence: therapeutic |
CTD |
PMID:23333834, PMID:16696922 |
RGD:1624171 |
NCBI chr 7:93,798,580...93,826,586
Ensembl chr 7:93,798,545...93,826,665
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
treatment |
IDA IEP ISO |
|
RGD |
PMID:23052485, PMID:21690068, PMID:20370892 |
RGD:7245941, RGD:8661761, RGD:8661729 |
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
treatment |
ISO IEP IDA |
human protein in rat model |
RGD |
PMID:21463515, PMID:21690068, PMID:23052485 |
RGD:5131255, RGD:8661761, RGD:7245941 |
NCBI chr 5:163,136,390...163,167,299
Ensembl chr 5:163,136,390...163,167,299
|
|
G |
Trpv2 |
transient receptor potential cation channel, subfamily V, member 2 |
treatment |
ISO |
|
RGD |
PMID:25869297 |
RGD:9999444 |
NCBI chr10:48,903,540...48,925,036
Ensembl chr10:48,903,540...48,925,030
|
|
G |
Txndc5 |
thioredoxin domain containing 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326410 |
|
NCBI chr17:26,925,828...26,953,981
Ensembl chr17:26,925,828...26,953,970
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9598899 PMID:26221077 |
|
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
G |
Vim |
vimentin |
|
IDA |
|
RGD |
PMID:7516431 |
RGD:6480480 |
NCBI chr17:80,882,715...80,891,200
Ensembl chr17:80,882,666...80,891,212
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO IDA |
|
RGD |
PMID:21998117, PMID:19055696 |
RGD:5685376, RGD:5685612 |
NCBI chr 1:42,169,307...42,177,582
Ensembl chr 1:42,169,501...42,177,582
|
|
G |
Xdh |
xanthine dehydrogenase |
|
IEP |
protein:increased expression:brain, mitochondrion |
RGD |
PMID:25870945 |
RGD:13208957 |
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
|
|
G |
Xylt1 |
xylosyltransferase 1 |
|
IEP |
mRNA:decreased expression:articular cartilage |
RGD |
PMID:19001053 |
RGD:2313142 |
NCBI chr 1:186,939,698...187,264,758
Ensembl chr 1:187,149,453...187,261,632
|
|
|
G |
A2m |
alpha-2-macroglobulin |
treatment |
IDA |
|
RGD |
PMID:1710603 |
RGD:10046021 |
NCBI chr 4:154,309,426...154,359,138
Ensembl chr 4:154,309,426...154,359,137
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
IEP |
|
RGD |
PMID:15878627 |
RGD:1559178 |
NCBI chr 6:43,400,525...43,448,280
Ensembl chr 6:43,400,528...43,448,280
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
ISO |
|
RGD |
PMID:9670863 |
RGD:2325244 |
NCBI chr 1:212,317,510...212,332,895
Ensembl chr 1:212,317,848...212,330,349
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
IEP |
protein:altered expression:spinal cord (rat) |
RGD |
PMID:19246105 |
RGD:2313022 |
NCBI chr20:5,161,350...5,167,176
Ensembl chr20:5,161,333...5,166,448
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
|
IEP |
mRNA,protein:increased expression:spinal cord |
RGD |
PMID:20155814 |
RGD:14348972 |
NCBI chr 1:40,816,130...40,906,582
Ensembl chr 1:40,816,107...40,906,581
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
|
RGD |
PMID:15328042 |
RGD:5509618 |
NCBI chr10:56,953,692...56,962,145
Ensembl chr10:56,953,691...56,962,161
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
severity |
ISO |
|
RGD |
PMID:28119027 |
RGD:14392778 |
NCBI chr 7:138,704,124...138,707,221
Ensembl chr 7:138,704,126...138,707,221
|
|
G |
Anxa1 |
annexin A1 |
|
IEP |
protein:increased expression:brain, astrocyte, macrophage |
RGD |
PMID:9472682 |
RGD:2306942 |
NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012
|
|
G |
Apoe |
apolipoprotein E |
|
IEP |
|
RGD |
PMID:28578430 |
RGD:13703134 |
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
|
|
G |
Aqp4 |
aquaporin 4 |
disease_progression severity |
ISO IEP |
|
RGD |
PMID:21056916, PMID:23707078, PMID:21157915, PMID:19660138 |
RGD:5148015, RGD:8696030, RGD:5490117, RGD:5490116 |
NCBI chr18:6,766,009...6,782,757
Ensembl chr18:6,765,945...6,782,996
|
|
G |
B2m |
beta-2 microglobulin |
|
ISO |
|
RGD |
PMID:15837577 |
RGD:6482690 |
NCBI chr 3:114,087,287...114,093,311
Ensembl chr 3:114,087,287...114,093,309
|
|
G |
B4galt6 |
beta-1,4-galactosyltransferase 6 |
|
ISO |
mRNA:increased expression:astrocyte |
RGD |
PMID:25216636 |
RGD:14390079 |
NCBI chr18:15,462,913...15,525,584
Ensembl chr18:15,462,913...15,525,579
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
IEP |
|
RGD |
PMID:23212569 |
RGD:10059360 |
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
C3 |
complement C3 |
|
IEP |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:22320401 |
RGD:7175513 |
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
C6 |
complement C6 |
severity |
IAGP |
|
RGD |
PMID:11970970 |
RGD:625607 |
NCBI chr 2:54,460,333...54,533,801
Ensembl chr 2:54,466,280...54,533,797
|
|
G |
Cacna1b |
calcium voltage-gated channel subunit alpha1 B |
|
IEP |
|
RGD |
PMID:11353727 |
RGD:1580151 |
NCBI chr 3:1,740,026...1,924,959
Ensembl chr 3:1,740,024...1,924,827
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
no_association |
ISO |
|
RGD |
PMID:19563774 |
RGD:5684360 |
NCBI chr 1:184,184,018...184,188,922
Ensembl chr 1:184,184,020...184,188,911
|
|
G |
Casp3 |
caspase 3 |
|
IEP |
protein:increased activity, increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp8 |
caspase 8 |
|
IEP |
protein:increased activity, increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Casp9 |
caspase 9 |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:18521931 |
RGD:2311436 |
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cav3 |
caveolin 3 |
onset |
IEP |
Protein:increased expression:spinal cord, astrocyte |
RGD |
PMID:15925413 |
RGD:1582168 |
NCBI chr 4:144,382,945...144,398,919
Ensembl chr 4:144,382,945...144,398,917
|
|
G |
Cblb |
Cbl proto-oncogene B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20453840 |
|
NCBI chr11:51,037,383...51,202,761
Ensembl chr11:51,037,393...51,202,820
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
|
IEP |
mRNA:decreased expression:lymph node |
RGD |
PMID:19865101 |
RGD:4145472 |
NCBI chr10:69,534,976...69,537,836
Ensembl chr10:69,534,933...69,537,882
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
|
IEP |
mRNA:increased expression:lymph node |
RGD |
PMID:19865101 |
RGD:4145472 |
NCBI chr10:69,434,965...69,439,566
Ensembl chr10:69,434,941...69,439,575
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:spinal cord mRNA:decreased expression:lymph node mRNA:increased expression:optic chiasma (rat) |
RGD |
PMID:17666800, PMID:19865101, PMID:11241588 |
RGD:2307114, RGD:4145472, RGD:8548888 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:17666800 |
RGD:2307114 |
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO IEP |
protein:increased expression:brain (mouse) mRNA:increased expression:spinal cord |
RGD |
PMID:15833367, PMID:17666800 |
RGD:4890027, RGD:2307114 |
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
IEP IMP |
|
RGD |
PMID:14655765, PMID:14512166 |
RGD:5688165, RGD:5688167 |
NCBI chr 8:132,996,646...133,002,201
Ensembl chr 8:132,996,649...133,002,201
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:9655467 |
RGD:632391 |
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:15034073 |
RGD:6893394 |
NCBI chr 8:133,026,539...133,040,999
Ensembl chr 8:133,029,625...133,040,997
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
IEP |
mRNA:increased expression:spinal cord, macrophage, microglia (rat) |
RGD |
PMID:17484785 |
RGD:4890436 |
NCBI chr 8:133,192,398...133,215,599
Ensembl chr 8:133,197,032...133,215,614
|
|
G |
Cd28 |
Cd28 molecule |
|
IMP |
|
RGD |
PMID:16061730 |
RGD:2307203 |
NCBI chr 9:67,546,408...67,573,858
Ensembl chr 9:67,546,408...67,571,871
|
|
G |
Cd4 |
Cd4 molecule |
treatment |
IEP IMP |
protein:decreased expression:T lymphocyte: |
RGD |
PMID:9138014, PMID:3097071 |
RGD:10058963, RGD:10058968 |
NCBI chr 4:157,381,862...157,408,357
Ensembl chr 4:157,383,052...157,408,176
|
|
G |
Cd80 |
Cd80 molecule |
|
IMP |
|
RGD |
PMID:9379015 |
RGD:6902906 |
NCBI chr11:64,815,201...64,855,293
Ensembl chr11:64,827,635...64,855,353
|
|
G |
Cd86 |
CD86 molecule |
resistance disease_progression |
ISO IEP |
protein:increased expression:spinal cord, blood vessel (rat) |
RGD |
PMID:10477557, PMID:20451260 |
RGD:4892227, RGD:4892207 |
NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795
|
|
G |
Ciita |
class II, major histocompatibility complex, transactivator |
|
IAGP |
|
RGD |
PMID:15821736 |
RGD:1358146 |
NCBI chr10:5,212,621...5,260,641
Ensembl chr10:5,213,350...5,260,608
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
IDA |
|
RGD |
PMID:21107918, PMID:7541143, PMID:10650887 |
RGD:6483335, RGD:6483353, RGD:6483351 |
NCBI chr10:88,490,798...88,497,357
Ensembl chr10:88,490,798...88,497,356
|
|
G |
Comt |
catechol-O-methyltransferase |
treatment |
ISO |
|
RGD |
PMID:25242632 |
RGD:13450949 |
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
IEP |
|
RGD |
PMID:22768796 |
RGD:7243111 |
NCBI chr15:57,290,849...57,339,762
Ensembl chr15:57,290,849...57,339,760
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
ISO IEP |
protein:increased expression:spinal cord |
RGD |
PMID:21679768, PMID:20162860 |
RGD:5686852, RGD:5686863 |
NCBI chr 8:61,532,465...61,567,510
Ensembl chr 8:61,532,465...61,567,510
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
ISO |
|
RGD |
PMID:9379015 |
RGD:6902906 |
NCBI chr 9:67,699,397...67,706,068
Ensembl chr 9:67,699,379...67,706,065
|
|
G |
Ctsc |
cathepsin C |
|
IEP |
|
RGD |
PMID:843913 |
RGD:1599653 |
NCBI chr 1:151,918,514...151,949,979
Ensembl chr 1:151,918,571...151,949,983
|
|
G |
Ctss |
cathepsin S |
|
ISO |
|
RGD |
PMID:21439785 |
RGD:5686915 |
NCBI chr 2:197,655,780...197,679,768
Ensembl chr 2:197,655,786...197,679,458
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:16053521 |
RGD:4891973 |
NCBI chr19:10,644,267...10,654,861
Ensembl chr19:10,644,244...10,653,800
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
IEP IMP |
|
RGD |
PMID:16053521, PMID:24706865 |
RGD:4891973, RGD:9491767 |
NCBI chr 8:128,740,756...128,754,514
Ensembl chr 8:128,740,756...128,754,514
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19616545 |
RGD:7257694 |
NCBI chr 9:81,427,275...81,435,065
Ensembl chr 9:81,427,730...81,434,102
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
IMP |
|
RGD |
PMID:21038468 |
RGD:5135506 |
NCBI chr X:71,614,346...71,616,997
Ensembl chr X:71,614,346...71,616,997
|
|
G |
Dab2 |
DAB adaptor protein 2 |
disease_progression |
IEP |
|
RGD |
PMID:21890121 |
RGD:7243155 |
NCBI chr 2:55,747,353...55,768,848
Ensembl chr 2:55,747,318...55,768,270
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:17947672 |
RGD:6482235 |
NCBI chr 1:57,318,621...57,326,732
Ensembl chr 1:57,318,708...57,327,379
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
|
ISO |
|
RGD |
PMID:15306813 |
RGD:7775013 |
NCBI chr13:104,284,660...104,321,455
Ensembl chr13:104,284,660...104,321,455
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
disease_progression |
IEP |
|
RGD |
PMID:19524108 |
RGD:9685491 |
NCBI chr 1:259,692,020...259,818,922
Ensembl chr 1:259,739,955...259,819,494
|
|
G |
Epo |
erythropoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18382691 |
|
NCBI chr12:22,274,828...22,278,268
Ensembl chr12:22,274,828...22,278,266
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30661753 |
|
NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
|
RGD |
PMID:21565615, PMID:21182085 |
RGD:5508732, RGD:5508735 |
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:10944459 |
RGD:12903984 |
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Fcgr2a |
Fc fragment of IgG receptor IIa |
|
ISO |
|
RGD |
PMID:12576552 |
RGD:5508383 |
NCBI chr13:91,146,878...91,163,691
Ensembl chr13:91,168,973...91,198,036 Ensembl chr13:91,168,973...91,198,036
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:8929896, PMID:9814819 |
RGD:8655647, RGD:9831448 |
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
treatment |
ISO |
|
RGD |
PMID:18721816 |
RGD:10402153 |
NCBI chr12:9,033,993...9,205,886
Ensembl chr12:9,034,308...9,205,905
|
|
G |
Foxo3 |
forkhead box O3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27742544 |
|
NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144
|
|
G |
Ghrh |
growth hormone releasing hormone |
resistance |
ISO |
|
RGD |
PMID:21846799 |
RGD:5687168 |
NCBI chr 3:153,449,124...153,468,794
Ensembl chr 3:153,449,125...153,468,794
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
treatment |
IDA |
|
RGD |
PMID:19620309 |
RGD:12905041 |
NCBI chr 4:145,674,157...145,678,066
Ensembl chr 4:145,674,157...145,678,066
|
|
G |
Gjc2 |
gap junction protein, gamma 2 |
|
ISO |
protein:decreased expression:white matter of spinal cord, gap junction (mouse) |
RGD |
PMID:22461072 |
RGD:13208593 |
NCBI chr10:45,526,740...45,535,520
Ensembl chr10:45,526,745...45,534,570
|
|
G |
Gli1 |
GLI family zinc finger 1 | |